Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Medizinische Klinik - Intensivmedizin und Notfallmedizin
Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin 2/2020

30.04.2020 | Septischer Schock | Leitlinien und Empfehlungen

S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge

Langfassung

verfasst von: Prof. Dr. med. F. M. Brunkhorst, M. A. Weigand, M. Pletz, P. Gastmeier, S. W. Lemmen, A. Meier-Hellmann, M. Ragaller, A. Weyland, G. Marx, M. Bucher, H. Gerlach, B. Salzberger, B. Grabein, T. Welte, K. Werdan, S. Kluge, H. G. Bone, C. Putensen, R. Rossaint, M. Quintel, C. Spies, B. Weiß, S. John, M. Oppert, A. Jörres, T. Brenner, G. Elke, M. Gründling, K. Mayer, A. Weimann, T. W. Felbinger, H. Axer, Deutsche Sepsis Gesellschaft e. V.

Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin | Sonderheft 2/2020

Einloggen, um Zugang zu erhalten

Auszug

Deutsche Sepsis Gesellschaft e. V. (federführend) …
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
Der Begriff „initial resuscitation“ aus der SSC-Leitlinie wird im Kapitel A mit hämodynamischer Stabilisierung übersetzt.
 
Literatur
1.
Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801–810PubMedPubMedCentral
2.
Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552PubMed
3.
Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4):1250–1256PubMed
4.
Shankar-Hari M, Phillips GS, Levy ML et al (2016) Sepsis definitions task force: developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:775–787PubMedPubMedCentral
5.
Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655PubMed
6.
Churpek MM, Zadravecz FJ, Winslow C, Howell MD, Edelson DP (2015) Incidence and prognostic value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients. Am J Respir Crit Care Med 192:958–964PubMedPubMedCentral
7.
Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372:1629–1638PubMed
8.
9.
Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign guidelines committee including the pediatric subgroup: surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228PubMedPubMedCentral
10.
11.
Martin GS, Mannino DM, Eaton S et al (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554PubMed
12.
13.
14.
Zingg W, Holmes A, Dettenkofer M et al (2015) Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis 15:212–224PubMed
15.
Price L, MacDonald J, Melone L et al (2018) Effectiveness of national and subnational infection prevention and control interventions in high-income and upper-middle-income countries: a systematic review. Lancet Infect Dis 18(5):e159–e171PubMed
16.
17.
Haley RW, Culver DH, White JW et al (1985) The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 121:182–205PubMed
18.
Mermel LA, Jefferson J, Blanchard K et al (2013) Reducing Clostridium difficile incidence, colectomies, and mortality in the hospital setting: a successful multidisciplinary approach. Jt Comm J Qual Patient Saf 39:298–305PubMed
19.
20.
(2013) Surveillance of nosocomial infections as well as the detection of pathogens with special resistance and multi-resistance. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(4):580–583
21.
Schwab F, Meyer E, Geffers C, Gastmeier P et al (2012) Understaffing, overcrowding, inappropriate nurse:ventilated patient ratio and nosocomial infections: which parameter is the best reflection of deficits? J Hosp Infect 80(2):133–139PubMed
22.
Birnbach DJ, Nevo I, Scheinman SR, Fitzpatrick M, Shekhter I, Lombard JL (2010) Patient safety begins with proper planning: a quantitative method to improve hospital design. Qual Saf Health Care 19:462–465PubMed
23.
McLaws ML, Pantle AC, Fitzpatrick KR, Hughes CF (2009) Improvements in hand hygiene across New South Wales public hospitals: clean hands save lives, part III. Med J Aust 191(Suppl):S18–S24PubMed
24.
Koff MD, Loftus RW, Burchman CC et al (2009) Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a novel Device. Anesthesiology 110:978–985PubMed
25.
Thomas BW, Berg-Copas GM, Vasquez DG, Jackson BL, Wetta-Hall R (2009) Conspicuous vs customary location of hand hygiene agent dispensers on alcohol-based hand hygiene product usage in an intensive care unit. J Am Osteopath Assoc 109:263–267PubMed
26.
Whitby M, McLaws ML (2004) Handwashing in healthcare workers: accessibility of sink location does not improve compliance. J Hosp Infect 58:247–253PubMed
27.
Jang JH, Wu S, Kirzner D et al (2010) Focus group study of hand hygiene practice among healthcare workers in a teaching hospital in Toronto, Canada. Infect Control Hosp Epidemiol 31:144–150PubMed
28.
Händehygiene in Einrichtungen des Gesundheitswesens : Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut (RKI). Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2016;59(9):1189–220.
29.
Engel C, Brunkhorst FM, Bone H‑G et al (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33(4):606–618PubMed
30.
von Baum H, Schweiger B, Welte T et al (2011) How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia. Eur Respir J 37(5):1151–1157
31.
Dalhoff K, Abele-Horn M, Andreas S et al (2017) Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie – Update
32.
Hagel S, Ludewig K, Moeser A et al (2016) Characteristics and management of patients with influenza in a German hospital during the 2014/2015 influenza season. Infection 44(5):667–672PubMed
33.
Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy collaborative group: early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377PubMed
34.
Peake SL, Delaney A, Bailey M et al (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371(16):1496–1506PubMed
35.
Yealy DM, Kellum JA, Huang DT et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370(18):1683–1693PubMed
36.
Mouncey PR, Osborn TM, Power GS et al (2015) ProMIse trial investiga tors: trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372:1301–1311PubMed
37.
Levy MM, Dellinger RP, Townsend SR et al (2010) Surviving sepsis campaign: the surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 38:367–374PubMed
38.
Levy MM, Rhodes A, Phillips GS et al (2015) Surviving Sepsis Campaign: association between performance metrics and Outcomes in a 7.5-year study. Crit Care Med 43:3–12PubMed
39.
Andrews B, Semler MW, Muchemwa L, Kelly P, Lakhi S, Heimburger DC et al (2017) Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension. JAMA 318:1233PubMedPubMedCentral
40.
Leisman DE, Doerfler ME, Ward MF et al (2017) Survival benefit and cost savings from compliance with a simplified 3‑Hour Sepsis Bundle in a Series of prospective, multisite, observational cohors. Crit Care Med 45:395–406PubMed
41.
Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376:2235–2244PubMedPubMedCentral
42.
Leisman DE, Goldman C, Doerfler ME et al (2017) Patterns and outcomes associated with timeliness of initial crystalloid resuscitation in a prospective sepsis and septic shock cohort. Crit Care Med 45:1596–1606PubMed
43.
Boulain T, Garot D, Vignon P, Lascarrou JB, Desachy A, Botoc V, Follin A, Frat JP, Bellec F, Quenot JP, Mathonnet A, Dequin PF and for the Clinical Research in Intensive Care and Sepsis (CRICS) Group: Prevalence of low central venous oxygensat uration in the first hours of intensive care unit admission and associated mortality in septic shock patients: a prospective multicentre study. (2014) Dequin PF and for the Clinical Research in Intensive Care and Sepsis (CRICS) Group: prevalence of low central venous oxygensat uration in the first hours of intensive care unit admission and associated mortality in septic shock patients: a prospective multicentre study. Crit Care 18:609PubMedPubMedCentral
44.
45.
Cecconi M, De Backer D, Antonelli M et al (2014) Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 40:1795–1815PubMedPubMedCentral
46.
American College of Cardiology Foundation Appropriate Use Criteria Task Force, ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography (2011) A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians. J Am Coll Cardiol 57:1126–1166
47.
Eskesen TG, Wetterslev M, Perner A (2016) Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness. Intensive Care Med 42:324–332PubMed
48.
Monnet X, Marik P, Teboul JL (2016) Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med 42:1935–1947PubMed
49.
FENICE Investigators, ESICM Trial Group, Cecconi M, Hofer C, Teboul JL et al (2015) Fluid challenges in intensive care: the FENICE study: A global inception cohort study. Intensive Care Med 41:1529–1537
50.
51.
Kelm DJ, Perrin JT, Cartin-Ceba R, Gajic O, Schenck L, Kenned CC (2015) Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock 43:68–73PubMedPubMedCentral
52.
Boyd JH, Forbes J, Nakada T, Walley KR, Russell JA (2011) Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39:259–265PubMed
53.
Acheampong A, Vincent JL (2015) A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care 16:251
54.
Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettilä V et al (2016) Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med 42:1695–1705PubMed
55.
Hjortrup PB, Haas N, Wetterslev J, Lange T, Bundgaard H, Rasmussen BS, Dey N, Wilkman E, Christensen L, Lodahl D, Bestle M, Perner A (2017) Effects of fluid restriction on measures of circulatory efficacy in adults with septic shock. Acta Anaesthesiol Scand 61:390–398PubMed
56.
LeDoux D, Astiz ME, Carpati CM et al (2000) Effects of perfusion pres sure on tissue perfusion in septic shock. Crit Care Med 28:2729–2732PubMed
57.
Bourgoin A, Leone M, Delmas A et al (2005) Increasing mean arterial pres sure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 33:780–786PubMed
58.
Thooft A, Favory R, Salgado DR et al (2011) Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care 15:R222PubMedPubMedCentral
59.
SEPSISPAM Investigators, Asfar P, Meziani F, Hamel JF et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370:1583–1593
60.
Canadian Critical Care Trials Group, Lamontagne F, Meade MO, Höbert PC et al (2016) Higher versus lower blood pressure targets for vaso pressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med 42:542–550
61.
Levy B (2006) Lactate and shock state: the metabolic view. Curr Opin Crit Care 12:315–321PubMed
62.
Casserly B, Phillips GS, Schorr C et al (2015) Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sep sis Campaign database. Crit Care Med 43:567–573PubMed
63.
LACTATE study group, Jansen TC, van Bommel J, Schoonderbeek FJ et al (2010) Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 182:752–761
64.
Emergency Medicine Shock Research Network (EMShockNet) Investigators, Jones AE, Shapiro NI, Trzeciak S et al (2010) Lactate Clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303:739–746
65.
Lyu X, Xu Q, Cai G et al (2015) Efficacies of fluid resuscitation as guided by lactate Clearance rate and central venous oxygen saturation in patients with septic shock. Zhonghua Yi Xue Za Zhi 95:496–500PubMed
66.
Tian HH, Han SS, Lv CJ et al (2012) The effect of early goal lactate clear ance rate on the Outcome of septic shock patients with severe pneumonia. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 24:42–45PubMed
67.
Yu B, Tian HY, Hu ZJ et al (2013) Comparison of the effect of fluid resusci tation as guided either by lactate Clearance rate or by central venous oxygen saturation in patients with sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 25:578–583
68.
Gu WJ, Zhang Z, Bakker J (2015) Early lactate Clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials. Intensive Care Med 41:1862–1863PubMed
69.
Simpson SQ, Gaines M, Hussein Y et al (2016) Early goal-directed therapy for severe sepsis and septic shock: a living systematic review. J Crit Care 36:43–48PubMed
70.
Dellinger RP (2015) Foreword. The future of sepsis performance improve ment. Crit Care Med 43:1787–1789PubMed
71.
Murphy DJ, Ogbu OC, Coopersmith CM (2015) ICU director data: using data to assess value, inform local change, and relate to the external world. Chest 147:1168–1178PubMedPubMedCentral
72.
Black MD, Schorr C, Levy MM (2012) Knowledge translation and the multi faceted intervention in the intensive care unit. Crit Care Med 40:1324–1328PubMed
73.
Gatewood MO, Wemple M, Greco S et al (2015) A quality improvement project to improve early sepsis care in the emergency department. BMJ Qual Saf 24:787–795PubMed
74.
Hayden GE, Tuuri RE, Scott R et al (2016) Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED. Am J Emerg Med 34(1):1–9PubMed
75.
Jones SL, Ashton CM, Kiehne L et al (2015) Reductions in sepsis mortality and costs after design and implementation of a nurse-based early recognition and response program. Jt Comm J Qual Patient Saf 41:483–491PubMedPubMedCentral
76.
Damiani E, Donati A, Serafini G et al (2015) Effect of performance improve ment programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS ONE 10:e125827PubMedPubMedCentral
77.
Rhodes A, Phillips G, Beale R et al (2015) The surviving sepsis campaign bundles and outcome: results from the international multicentre prevalence study on sepsis (the IMpreSS study). Intensive Care Med 41:1620–1628PubMed
78.
Zadroga R, Williams DN, Gottschall R et al (2013) Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy. Clin Infect Dis 56:790–797PubMed
79.
Kanegaye JT, Soliemanzadeh P, Bradley JS (2001) Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 108:1169–1174PubMed
80.
Pollack LA, van Santen KL, Weiner LM et al (2016) Antibiotic stewardship programs in U.S. acute care hospitals: findings from the 2014 national healthcare safety network annual hospital survey. Clin Infect Dis 63:443–449PubMed
81.
Cardoso T, Carneiro AH, Ribeiro O et al (2010) Reducing mortality in severe sepsis with the implementation of a core 6‑hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study). Crit Care 14:R83PubMedPubMedCentral
82.
De Sousa AG, Fernandes JCJ, Santos GPD et al (2008) The impact of each action in the Surviving Sepsis Campaign measures on hospital mortality of patients with severe sepsis/septic shock. Einstein 6(3):323–327
83.
84.
Weiss CH, Persell SD, Wunderink RG et al (2012) Empiric antibiotic, mechanical ventilation, and central venous catheter duration as potential factors mediating the effect of a checklist prompting intervention on mortality: an exploratory analysis. BMC Health Serv Res 12:198PubMedPubMedCentral
85.
Edusepsis Study Group, Ferrer R, Artigas A, Suarez D et al (2009) Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 180:861–866
86.
Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMed
87.
88.
Weinstein MP, Reller LB, Murphy JR et al (1983) The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 5:35–53PubMed
89.
Li J, Plorde JJ, Carlson LG (1994) Effects of volume and periodicity on blood cultures. J Clin Microbiol 32:2829–2831PubMedPubMedCentral
90.
Baron EJ, Miller JM, Weinstein MP et al (2013) A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis 57:e22–e121PubMed
91.
O’Grady NP, Alexander M, Burns LA et al (2011) Healthcare Infection Control Practices Advisory Committee (HICPAC): guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52:e162–e193PubMedPubMedCentral
92.
Blot F, Schmidt E, Nitenberg G et al (1998) Earlier positivity of centralvenous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 36:105–109PubMedPubMedCentral
93.
Kaasch AJ, Rieg S, Hellmich M et al (2014) Differential time to positivity is not predictive for central line-related Staphylococcus aureus bloodstream infection in routine clinical care. J Infect 68:58–61PubMed
94.
Malgrange VB, Escande MC, Theobald S (2001) Validity of earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for diagnosing catheter-related bacteremia in cancer patients. J Clin Microbiol 39:274–278PubMedPubMedCentral
95.
O’Grady NP, Barie PS, Bartlett JG et al (2008) American College of Critical Care Medicine; Infectious Diseases Society of America: guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 36:1330–1349PubMed
96.
Mermel LA, Allon M, Bouza E et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45PubMed
97.
Boyce JM, Nadeau J, Dumigan D et al (2013) Obtaining blood cultures by venipuncture versus from central lines: impact on blood culture contamination rates and potential effect on central line-associated bloodstream infection reporting. Infect Control Hosp Epidemiol 34:1042–1047PubMed
98.
Beekmann SE, Diekema DJ, Huskins WC et al (2012) Infectious Diseases Society of America Emerging Infections Network: diagnosing and reporting of central line-associated bloodstream infections. Infect Control Hosp Epidemiol 33:875–882PubMed
99.
Garcia RA, Spitzer ED, Beaudry J et al (2015) Multidisciplinary team review of best practices for collection and handling of blood cultures to determine effective interventions for increasing the yield of truepositive bacteremias, reducing contamination, and eliminating falsepositive central line-associated bloodstream infections. Am J Infect Control 43(11):1222–1237PubMed
100.
Vincent JL, Brealey D, Libert N et al (2015) Rapid diagnosis of infections in the critically ill team: rapid diagnosis of infection in the critically ill, a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections. Crit Care Med 43:2283–2291PubMedPubMedCentral
101.
Makristathis A, Riss S, Hirschl AM (2014) A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures. Clin Microbiol Infect 20:O760–O763PubMed
102.
Tissari P, Zumla A, Tarkka E et al (2010) Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 375:224–230PubMed
103.
Niven DJ, Gaudet JE, Laupland KB et al (2015) Accuracy of peripheral thermometers for estimating temperature: a systematic review and meta-analysis. Ann Intern Med 163:768–779PubMed
104.
Ferrer R, Martin-Loeches I, Phillips G et al (2014) Empiric antibiotic treat ment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42:1749–1755PubMed
105.
Zhang D, Micek ST, Kollef MH (2015) Time to appropriate antibiotic therapy is an independent determinant of postinfection ICU and hospital lengths of stay in patients with sepsis. Crit Care Med 43:2133–2140PubMed
106.
Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group, Bagshaw SM, Lapinsky S, Dial S et al (2009) Acute kidney injury in septic shock: clinical Outcomes and impact of dura tion of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35:871–881
107.
Iscimen R, Cartin-Ceba R, Yilmaz M et al (2008) Risk factors for the devel opment of acute lung injury in patients with septic shock: an observa tional cohort study. Crit Care Med 36:1518–1522PubMed
108.
Garnacho-Montero J, Aldabo-Pallas T, Garnacho-Montero C et al (2006) Timing of adequate antibiotic therapy is a greater determinant of out come than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care 10:R111PubMedPubMedCentral
109.
Barie PS, Hydo LJ, Shou J et al (2005) Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect 6:41–54
110.
Barochia AV, Cui X, Vitberg D et al (2010) Bundled care for septic shock: an analysis of clinical trials. Crit Care Med 38:668–678PubMedPubMedCentral
111.
Gaieski DF, Mikkelsen ME, Band RA et al (2010) Impact of time to antibiot ics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38:1045–1053PubMed
112.
Kumar A (2016) Systematic bias in meta-analyses of time to antimicrobial in sepsis studies. Crit Care Med 44:e234–e235PubMed
113.
Shirakura Y, Kuriyama A (2016) Timing of antibiotic administration in sepsis and septic shock: the impact that a meta-analysis does not depict. Crit Care Med 44:e1004PubMed
114.
preSABATO study group, Kaasch AJ, Rieg S, Kuetscher J et al (2013) Delay in the administration of appropriate antimicrobial therapy in Staphy lococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study. Infection 41:979–985
115.
Corona A, Bertolini G, Lipman J et al (2010) Antibiotic use and impact on Outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC). J Antimicrob Chemother 65:1276–1285PubMed
116.
Giner AM, Kuster SP, Zbinden R et al (2011) Initial management of and Outcome in patients with pneumococcal bacteremia: a retrospec tive study at a Swiss university hospital, 2003–2009. Infection 39:519–526PubMed
117.
Lin MY, Weinstein RA, Hota B (2008) Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neu tropenia. Antimicrob Agents Chemother 52:3188–3194PubMedPubMedCentral
118.
Amaral AC, Fowler RA, Pinto R et al (2016) Cooperative antimicrobial therapy of septic shock database research group: patient and organizational factors associated with delays in antimicrobial therapy for septic shock. Crit Care Med 44:2145–2153PubMed
119.
Funk DJ, Kumar A (2011) Antimicrobial therapy for life-threatening infections: speed is life. Crit Care Clin 27:53–76PubMed
120.
Petitpas F, Guenezan J, Vendeuvre T et al (2016) Use of intra-osseous access in adults: a systematic review. Crit Care 20:102PubMedPubMedCentral
121.
Buck ML, Wiggins BS, Sesler JM (2007) Intraosseous drug administration in children and adults during cardiopulmonary resuscitation. Ann Pharmacother 41:1679–1686PubMed
122.
Romanelli G, Cravarezza P (1995) Intramuscular meropenem in the treat ment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group. J Antimicrob Chemother 36(Suppl A):109–119PubMed
123.
Cormio L, Berardi B, Callea A et al (2002) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU Int 90:700–702PubMed
124.
Barbhaiya RH, Knupp CA, Tenney J et al (1990) Safety, tolerance, and phar-macokinetics of cefepime administered intramuscularly to healthy subjects. J Clin Pharmacol 30:900–910PubMed
125.
Kumar A, Ellis P, Arabi Y et al (2009) Cooperative Antimicrobial Therapy of Septic Shock Database Research Group: initiation of inappropri ate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:1237–1248PubMed
126.
Ibrahim EH, Sherman G, Ward S et al (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient out comes in the ICU setting. Chest 118:146–155PubMed
127.
Paul M, Shani V, Muchtar E et al (2010) Systematic review and meta-analy sis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54:4851–4863PubMedPubMedCentral
128.
Kreger BE, Craven DE, McCabe WR (1980) Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 68:344–355PubMed
129.
Mermel LA, Maki DG (1993) Detection of bacteremia in adults: conse quences of culturing an inadequate volume of blood. Ann Intern Med 119:270–272PubMed
130.
Bow EJ, Evans G, Fuller J et al (2010) Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol 21:e122–e150PubMedPubMedCentral
131.
Connolly S (2011) Clinical practice guidelines: burn patient management. ACI statewide burn injury service. NSW Agency for Clinical Innovation, Chatswood
132.
ESCMID Fungal Infection Study Group, Cornely OA, Bassetti M, Calandra T et al (2012) ESCMID* guideline for the diagnosis and manage ment of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7):19–37
133.
Kalil AC, Metersky ML, Klompas M et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of america and the American thoracic society. Clin Infect Dis 63:e61–e111PubMedPubMedCentral
134.
Liu C, Bayer A, Cosgrove SE et al (2011) Infectious Diseases Society of America: clinical practice guidelines by the infectious dis eases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52:e18–e55PubMed
135.
Pappas PG, Kauffman CA, Andes DR et al (2016) Clinical practice guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62:e1–e50PubMed
136.
Penack O, Becker C, Buchheidt D et al (2014) Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Ann Hematol 93:1083–1095PubMedPubMedCentral
137.
German Society of Hematology and Oncology, Penack O, Buchheidt D, Christopeit M et al (2011) Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology. Ann Oncol 22:1019–1029
138.
Solomkin JS, Mazuski JE, Bradley JS et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guide lines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect 11:79–109
139.
Stevens DL, Bisno AL, Chambers HF et al (2014) Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 59:147–159PubMed
140.
Micek ST, Welch EC, Khan J et al (2010) Empiric combination antibiotic therapy is associated with improved Outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother 54:1742–1748PubMedPubMedCentral
141.
Pittet D, Monod M, Suter PM et al (1994) Candida colonization and sub sequent infections in critically ill surgical patients. Ann Surg 220:751–758PubMedPubMedCentral
142.
National Epidemiology of Mycoses Survey(NEMIS) Study Group, Blumberg HM, Jarvis WR, Soucie JM et al (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186
143.
Green DL (2005) Selection of an empiric antibiotic regimen for hospital acquired pneumonia using a unit and culture-type specific antibio gram. J Intensive Care Med 20:296–301PubMed
144.
Kaufman D, Haas CE, Edinger R et al (1998) Antibiotic susceptibility in the surgical intensive care unit compared with the hospital-wide antibio gram. Arch Surg 133:1041–1045PubMed
145.
Kerremans JJ, Verbrugh HA, Vos MC (2012) Frequency of microbio logically correct antibiotic therapy increased by infectious disease consultations and microbiological results. J Clin Microbiol 50:2066–2068PubMedPubMedCentral
146.
Guo Y, Gao W, Yang H et al (2016) De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: A meta-analysis. Heart Lung 45:454–459PubMed
147.
Working Group IAP/APA (2013) Acute Pancreatitis Guidelines: IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 13(4):e1–e15
148.
Wittau M, Mayer B, Scheele J et al (2011) Systematic review and meta analysis of antibiotic prophylaxis in severe acute pancreatitis. Scand J Gastroenterol 46:261–270PubMed
149.
Avni T, Levcovich A, Ad-El DD et al (2010) Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ 340:c241PubMedPubMedCentral
150.
151.
Moore RD, Smith CR, Lietman PS (1984) Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med 77:657–662PubMed
152.
Men P, Li HB, Zhai SD et al (2016) Association between the AUC0-24/MIC ratio of vancomycin and its clinical effectiveness: a systematic review and meta-analysis. PLoS ONE 11:e146224PubMedPubMedCentral
153.
Moise-Broder PA, Forrest A, Birmingham MC et al (2004) Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43:925–942PubMed
154.
Cooperative Antimicrobial Therapy of Septic Shock-CATSS Database Research Group, Zelenitsky S, Rubinstein E, Ariano R et al (2013) Vancomycin pharmacodynamics and survival in patients with meth icillin-resistant Staphylococcus aureus-associated septic shock. Int J Antimicrob Agents 41:255–260
155.
Forrest A, Nix DE, Ballow CH et al (1993) Pharmacodynamics of intra venous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 37:1073–1081PubMedPubMedCentral
156.
Preston SL, Drusano GL, Berman AL et al (1998) Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 279:125–129PubMed
157.
Drusano GL, Preston SL, Fowler C et al (2004) Relationship between fluoroquinolone area under the curve: minimum inhibitory con centration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis 189:1590–1597PubMed
158.
Kashuba AD, Nafziger AN, Drusano GL et al (1999) Optimizing aminogly coside therapy for nosocomial pneumonia caused by gram-negative bacteria. Antimicrob Agents Chemother 43:623–629PubMedPubMedCentral
159.
Schentag JJ, Smith IL, Swanson DJ et al (1984) Role for dual individualiza tion with cefmenoxime. Am J Med 77:43–50PubMed
160.
Crandon JL, Bulik CC, Kuti JL et al (2010) Clinical pharmacodynamics of cefepime in patients infected with pseudomonas aeruginosa. Antimicrob Agents Chemother 54:1111–1116PubMed
161.
McKinnon PS, Paladino JA, Schentag JJ (2008) Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T〉MIC) as predictors of Outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents 31:345–351PubMed
162.
Roberts JA, Abdul-Aziz MH, Davis JS et al (2016) Continuous versus intermittent β‑Lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials. Am J Respir Crit Care Med 194:681–691PubMed
163.
Barza M, Ioannidis JP, Cappelleri JC et al (1996) Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 312:338–345PubMedPubMedCentral
164.
Hatala R, Dinh T, Cook DJ (1996) Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 124:717–725PubMed
165.
van Zanten AR, Polderman KH, van Geijlswijk IM et al (2008) Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study. J Crit Care 23:422–430PubMed
166.
Zelenitsky SA, Ariano RE (2010) Support for higher ciprofloxacin AUC 24/MIC targets in treating Enterobacteriaceae bloodstream infection. J Antimicrob Chemother 65:1725–1732PubMed
167.
Dunbar LM, Wunderink RG, Habib MP et al (2003) High-dose, short course levofloxacin for community-acquired pneumonia: a new treat ment paradigm. Clin Infect Dis 37:752–760PubMed
168.
Rybak MJ, Lomaestro BM, Rotschafer JC et al (2009) Vancomycin thera peutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 49:325–327PubMed
169.
Matsumoto K, Takesue Y, Ohmagari N et al (2013) Practice guide lines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. J Infect Chemother 19:365–380PubMed
170.
Steinmetz T, Eliakim-Raz N, Goldberg E et al (2015) Association of van comycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis. Clin Microbiol Infect 21:665–673PubMed
171.
Mohamed AF, Karaiskos I, Plachouras D et al (2012) Application of a load ing dose of colistin methanesulfonate in critically ill patients: popula tion pharmacokinetics, protein binding, and prediction of bacterial kill. Antimicrob Agents Chemother 56:4241–4249PubMedPubMedCentral
172.
Pea F, Brollo L, Viale P et al (2003) Teicoplanin therapeutic drug moni toring in critically ill patients: a retrospective study emphasizing the importance of a loading dose. J Antimicrob Chemother 51:971–975PubMed
173.
Pea F, Viale P (2009) Bench-to-bedside review: appropriate antibiotic ther apy in severe sepsis and septic shock—does the dose matter? Crit Care 13:214PubMedPubMedCentral
174.
Wang JT, Fang CT, Chen YC et al (2001) Necessity of a loading dose when using vancomycin in critically ill patients. J Antimicrob Chemother 47:246PubMed
175.
Kumar A (2014) An alternate pathophysiologic paradigm of sepsis and sep tic shock: implications for optimizing antimicrobial therapy. Virulence 5:80–97PubMed
176.
Rhodes NJ, MacVane SH, Kuti JL et al (2014) Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes. Clin Infect Dis 59:905–907PubMed
177.
Lodise TP Jr, Lomaestro B, Drusano GL (2007) Piperacillin-tazobactam for pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis 44:357–363PubMed
178.
Yost RJ, Cappelletty DM, RECEIPT Study group (2011) The retrospective cohort of extended-infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study. Pharmacotherapy 31:767–775PubMed
179.
Falagas ME, Tansarli GS, Ikawa K et al (2013) Clinical Outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clin Infect Dis 56:272–282PubMed
180.
Yusuf E, Spapen H, Piörard D (2014) Prolonged vs intermittent infusion of piperacillin/tazobactam in critically ill patients: a narrative and sys tematic review. J Crit Care 29:1089–1095PubMed
181.
Mah GT, Mabasa VH, Chow I et al (2012) Evaluating Outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a quali tative systematic review. Ann Pharmacother 46:265–275PubMed
182.
Blot S, Koulenti D, Akova M et al (2014) Does contemporary vancomy cin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study. Crit Care 18:R99PubMedPubMedCentral
183.
DALI Study, Roberts JA, Paul SK, Akova M et al (2014) DALI: defining antibiotic levels in intensive care unit patients: are current β‑lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072–1083
184.
Taccone FS, Laterre PF, Spapen H et al (2010) Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock. Crit Care 14:R53PubMedPubMedCentral
185.
Rea RS, Capitano B, Bies R et al (2008) Suboptimal aminoglycoside dos ing in critically ill patients. Ther Drug Monit 30:674–681PubMed
186.
Kumar A, Safdar N, Kethireddy S et al (2010) A survival benefit of combina tion antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-ana lytic/meta-regression study. Crit Care Med 38:1651–1664PubMed
187.
Kumar A, Zarychanski R, Light B et al (2010) Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group: Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 38:1773–1785PubMed
188.
Al-Hasan MN, Wilson JW, Lahr BD et al (2009) Beta-lactam and fluoro quinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother 53:1386–1394PubMedPubMedCentral
189.
Delannoy PY, Boussekey N, Devos P et al (2012) Impact of combination therapy with aminoglycosides on the outcome of ICU-acquired bac teraemias. Eur J Clin Microbiol Infect Dis 31:2293–2299PubMedPubMedCentral
190.
Edusepsis Study Group, Díaz-Martín A, Martínez-González ML, Ferrer R et al (2012) Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mecha nisms of action reduces mortality. Crit Care 16:R223
191.
Martin-Loeches I, Lisboa T, Rodriguez A et al (2010) Combination antibi otic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 36:612–620PubMed
192.
German Study Group Competence Network Sepsis (SepNet), Brunkhorst FM, Oppert M, Marx G et al (2012) Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA 307:2390–2399
193.
CAPUCI Study Group, Rodríguez A, Mendia A, Sirvent JM et al (2007) Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med 35:1493–1498
194.
International Pneumococcal Study Group, Baddour LM, Yu VL, Klugman KP et al (2004) Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 170:440–444
195.
Hilf M, Yu VL, Sharp J et al (1989) Antibiotic therapy for pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 87:540–546PubMed
196.
Tumbarello M, Viale P, Viscoli C et al (2012) Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapen emase-producing K. pneumoniae: importance of combination ther apy. Clin Infect Dis 55:943–950PubMed
197.
Bass SN, Bauer SR, Neuner EA et al (2015) Impact of combination antimi crobial therapy on mortality risk for critically ill patients with carbape nem-resistant bacteremia. Antimicrob Agents Chemother 59:3748–3753PubMedPubMedCentral
198.
Poulikakos P, Tansarli GS, Falagas ME (2014) Combination antibiotic treatment versus monotherapy for multidrug-resistant, exten sively drug-resistant, and pandrug-resistant Acinetobacter infec tions: a systematic review. Eur J Clin Microbiol Infect Dis 33:1675–1685PubMed
199.
Falagas ME, Lourida P, Poulikakos P et al (2014) Antibiotic treatment of infections due to carbapenem-resistant enterobacteriaceae: sys tematic evaluation of the available evidence. Antimicrob Agents Chemother 58:654–663PubMedPubMedCentral
200.
Hu Y, Li L, Li W et al (2013) Combination antibiotic therapy versus mono therapy for pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies. Int J Antimicrob Agents 42:492–496PubMed
201.
Vardakas KZ, Tansarli GS, Bliziotis IA et al (2013) β‑Lactam plus amino glycoside or fluoroquinolone combination versus β‑lactam mono therapy for Pseudomonas aeruginosa infections: a meta-analysis. Int J Antimicrob Agents 41:301–310PubMed
202.
Stevens DL, Tanner MH, Winship J et al (1989) Severe group A strepto coccal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321:1–7PubMed
203.
Zimbelman J, Palmer A, Todd J (1999) Improved outcome of clindamy cin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 18:1096–1100PubMed
204.
Safdar N, Handelsman J, Maki DG (2004) Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A metaanalysis. Lancet Infect Dis 4:519–527PubMed
205.
Paul M, Soares-Weiser K, Leibovici L (2003) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 326:1111PubMedPubMedCentral
206.
207.
Morel J, Casoetto J, Jospö R et al (2010) De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care 14:R225PubMedPubMedCentral
208.
Joung MK, Lee JA, Moon SY et al (2011) Impact of de-escalation therapy on clinical Outcomes for intensive care unit-acquired pneumonia. Crit Care 15:R79PubMedPubMedCentral
209.
AZUREA Network Investigators, Leone M, Bechis C, Baumstarck K et al (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40:1399–1408
210.
Riccio LM, Popovsky KA, Hranjec T et al (2014) Association of excessive duration of antibiotic therapy for intra-abdominal infection with sub sequent extra-abdominal infection and death: a study of 2,552 con secutive infections. Surg Infect 15:417–424
211.
Aarts MA, Brun-Buisson C, Cook DJ et al (2007) Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve Outcome? Intensive Care Med 33:1369–1378PubMed
212.
Stevens V, Dumyati G, Fine LS et al (2011) Cumulative antibiotic expo sures over time and the risk of Clostridium difficile infection. Clin Infect Dis 53:42–48PubMed
213.
Goossens H (2009) Antibiotic consumption and link to resistance. Clin Microbiol Infect 15(Suppl 3):12–15PubMed
214.
PneumA Trial Group, Chastre J, Wolff M, Fagon JY et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneu monia in adults: a randomized trial. JAMA 290:2588–2598
215.
Choudhury G, Mandal P, Singanayagam A et al (2011) Seven-day antibi otic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis. Clin Microbiol Infect 17:1852–1858PubMed
216.
217.
Sawyer RG, Claridge JA, Nathens AB et al (2015) Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 372:1996–2005PubMedPubMedCentral
218.
Eliakim-Raz N, Yahav D, Paul M et al (2013) Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection—7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 68:2183–2191PubMed
219.
Rattan R, Allen CJ, Sawyer RG et al (2016) Patients with complicated intra-abdominal infection presenting with sepsis do not require longer duration of antimicrobial therapy. J Am Coll Surg 222:440–446PubMed
220.
Hepburn MJ, Dooley DP, Skidmore PJ et al (2004) Comparison of short course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med 164:1669–1674PubMed
221.
Chaudhry ZI, Nisar S, Ahmed U, Ali M (2000) Short course of antibiotic treatment in spontaneous bacterial peritonitis: a randomized con trolled study. J Coll Physicians Surg Pak 10(8):284–288
222.
Infectious Diseases Society of America, Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 52:e56–e93
223.
Jack L, Bal AM, Harte S et al (2016) International guidelines: the need to standardize the management of candidaemia. Infect Dis 48:779–781
224.
American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, Stroke Council, Baddour LM, Wilson WR, Bayer AS et al (2015) Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 132:1435–1486
225.
Weiss CH, Moazed F, McEvoy CA et al (2011) Prompting physicians to address a daily checklist and process of care and clinical outcomes: a single-site study. Am J Respir Crit Care Med 184:680–686PubMedPubMedCentral
226.
PCRAGA Study Group, Spanish Stem Cell Transplantation Group, Study Group of Medical Mycology of the Spanish Society of Clinical Microbiology and Infectious Diseases, Spanish Network for Research in InfectiousDiseases, Aguado JM, Vázquez L, Fernández-Ruiz M et al (2015) Serum galactomannan versus a combination of galacto mannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial. Clin Infect Dis 60:405–414
227.
Hou TY, Wang SH, Liang SX et al (2015) The screening performance of serum 1,3-beta-D-Glucan in patients with invasive fungal diseases: a meta-analysis of prospective cohort studies. PLoS ONE 10:e131602PubMedPubMedCentral
228.
Schuetz P, Briel M, Christ-Crain M et al (2012) Procalcitonin to guide ini tiation and duration of antibiotic treatment in acute respiratory infec tions: an individual patient data meta-analysis. Clin Infect Dis 55:651–662PubMedPubMedCentral
229.
Matthaiou DK, Ntani G, Kontogiorgi M et al (2012) An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med 38:940–949PubMed
230.
Prkno A, Wacker C, Brunkhorst FM et al (2013) Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and sep tic shock—a systematic review and meta-analysis. Crit Care 17:R291PubMedPubMedCentral
231.
Westwood M, Ramaekers B, Whiting P et al (2015) Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency depart ment settings: a systematic review and cost-effectiveness analysis. Health Technol Assess 19(96):1–236PubMedPubMedCentral
232.
Wacker C, Prkno A, Brunkhorst FM et al (2013) Procalcitonin as a diag nostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 13:426–435PubMed
233.
Soni NJ, Samson DJ, Galaydick JL et al (2013) Procalcitonin-guided anti biotic therapy: a systematic review and meta-analysis. J Hosp Med 8:530–540PubMed
234.
de Jong E, van Oers JA, Beishuizen A et al (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treat ment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 16:819–827PubMed
235.
Lesprit P, Landelle C, Girou E et al (2010) Reassessment of intrave nous antibiotic therapy using a reminder or direct counselling. J Antimicrob Chemother 65:789–795PubMed
236.
Paul M, Dickstein Y, Raz-Pasteur A (2016) Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. Clin Microbiol Infect 22:960–967PubMed
237.
Jimenez MF, Marshall JC, International Sepsis Forum (2001) Source control in the management of sepsis. Intensive Care Med 27(Suppl 1):S49–S62PubMed
238.
Azuhata T, Kinoshita K, Kawano D et al (2014) Time from admission to initi ation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care 18:R87PubMedPubMedCentral
239.
Bloos F, Thomas-Rüddel D, Rüddel H et al (2014) MEDUSA Study Group: Impact of compliance with infection management guidelines on out come in patients with severe sepsis: a prospective observational multi-center study. Crit Care 18:R42PubMedPubMedCentral
240.
FEAST Trial Group, Maitland K, Kiguli S, Opoka RO et al (2011) Mortality after fluid bolus in African children with severe infection. N Engl J Med 364:2483–2495
241.
Acheampong A, Vincent JL (2015) A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care 19:251PubMedPubMedCentral
242.
Brotfain E, Koyfman L, Toledano R et al (2016) Positive fluid balance as a major predictor of clinical Outcome of patients with sepsis/septic shock after ICU discharge. Am J Emerg Med 34:2122–2126PubMed
243.
Mitchell KH, Carlbom D, Caldwell E et al (2015) Volume overload: prevalence, risk factors, and functional outcome in survivors of septic shock. Ann Am Thorac Soc 12:1837–1844PubMedPubMedCentral
244.
de Oliveira FS, Freitas FG, Ferreira EM et al (2015) Positive fluid balance as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock. J Crit Care 30:97–101PubMed
245.
Malbrain ML, Marik PE, Witters I et al (2014) Fluid overload, de-resuscitation, and Outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther 46:361–380PubMed
246.
Yunos NM, Bellomo R, Hegarty C et al (2012) Association between a chloride-liberal vs chloride-restrictive intravenous fluid administra tion strategy and kidney injury in critically ill adults. JAMA 308:1566–1572PubMed
247.
248.
Semler M et al (2018) Balanced crystalloids versus saline in critically ill adults. N Engl J Med 378:829–839PubMedPubMedCentral
249.
Fluids in Sepsis and Septic Shock Group, Rochwerg B, Alhazzani W, Sindi A et al (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161:347–355
250.
SPLIT Investigators, ANZICS CTG, Young P, Bailey M, Beasley R et al (2015) Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial. JAMA 314:1701–1710
251.
Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, Stollings JL, Kumar AB, Hughes CG, Hernandez A, Guillamondegui OD, May AK, Weavind L, Casey JD, Siew ED, Shaw AD, Bernard GR, Rice TW (2018) SMART investigators and the pragmatic critical care research group. Balanced crystalloids versus saline in critically ill adults. N Engl J Med 378(9):829–839PubMedPubMedCentral
252.
Annane D, Siami S, Jaber S et al (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310:1809–1817PubMed
253.
Haase N, Perner A, Hennings LI et al (2013) Hydroxyethyl starch 130/0.38 0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839PubMedPubMedCentral
254.
Day NP, Phu NH, Bethell DP et al (1996) The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemody namics in severe infection. Lancet 348:219–223PubMed
255.
De Backer D, Creteur J, Silva E et al (2003) Effects of dopamine, nor epinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 31:1659–1667PubMed
256.
Martin C, Papazian L, Perrin G et al (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 103:1826–1831PubMed
257.
Martin C, Viviand X, Leone M et al (2000) Effect of norepinephrine on the Outcome of septic shock. Crit Care Med 28:2758–2765PubMed
258.
259.
Levy B, Bollaert PE, Charpentier C et al (1997) Comparison of norepi nephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a pro spective, randomized study. Intensive Care Med 23:282–287PubMed
260.
Zhou SX, Qiu HB, Huang YZ et al (2002) Effects of norepinephrine, epi nephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. Acta Pharmacol Sin 23:654–658PubMed
261.
Mackenzie SJ, Kapadia F, Nimmo GR et al (1991) Adrenaline in treatment of septic shock: effects on haemodynamics and oxygen transport. Intensive Care Med 17:36–39PubMed
262.
Moran JL, O’Fathartaigh MS, Peisach AR et al (1993) Epinephrine as an inotropic agent in septic shock: a dose-profile analysis. Crit Care Med 21:70–77PubMed
263.
Yamazaki T, Shimada Y, Taenaka N et al (1982) Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis. Crit Care Med 10:432–435PubMed
264.
Regnier B, Rapin M, Gory G et al (1977) Haemodynamic effects of dopa mine in septic shock. Intensive Care Med 3:47–53PubMed
265.
Beck GC, Brinkkoetter P, Hanusch C, : et al (2004) Clinical review: immu-nomodulatory effects of dopamine in general inflammation. Crit Care 8(6):485–491PubMed
266.
Avni T, Lador A, Lev S et al (2015) Vasopressors for the treatment of septic shock: systematic review and meta-analysis. PLoS ONE 10:e129305PubMedPubMedCentral
267.
CAT Study investiga tors, Myburgh JA, Higgins A, Jovanovska A et al (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34:2226–2234
268.
Patel BM, Chittock DR, Russell JA et al (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576–582PubMed
269.
Dünser MW, Mayr AJ, Ulmer H et al (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107:2313–2319PubMed
270.
Lauzier F, Lévy B, Lamarre P et al (2006) Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 32:1782–1789PubMed
271.
Holmes CL, Walley KR, Chittock DR et al (2001) The effects of vasopres sin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27:1416–1421PubMed
272.
Malay MB, Ashton RC Jr, Landry DW et al (1999) Low-dose vasopres sin in the treatment of vasodilatory septic shock. J Trauma 47:699–703 (discussion 703)PubMed
273.
O’Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resis tant septic shock. Lancet 359:1209–1210PubMed
274.
Sharshar T, Blanchard A, Paillard M et al (2003) Circulating vasopressin levels in septic shock. Crit Care Med 31:1752–1758PubMed
275.
VASST Investigators, Russell JA, Walley KR, Singer J et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877–887
276.
VANISH Investigators, Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316:509–518
277.
Albanèse J, Leone M, Delmas A et al (2005) Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 33:1897–1902PubMed
278.
Morelli A, Ertmer C, Lange M et al (2008) Effects of short-term simultane ous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth 100:494–503PubMed
279.
Morelli A, Ertmer C, Rehberg S et al (2009) Continuous terlipressin ver sus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 13:R130PubMedPubMedCentral
280.
Zhou F, Mao Z, Zeng X et al (2015) Vasopressors in septic shock: a sys tematic review and network meta-analysis. Ther Clin Risk Manag 11:1047–1059PubMedPubMedCentral
281.
De Backer D, Aldecoa C, Njimi H et al (2012) Dopamine versus norepi nephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 40:725–730PubMed
282.
283.
Gattinoni L, Brazzi L, Pelosi P et al (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 333:1025–1032PubMed
284.
Hayes MA, Timmins AC, Yau EH et al (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330:1717–1722PubMed
285.
Hollenberg SM, Ahrens TS, Annane D et al (2004) Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32:1928–1948PubMed
286.
CATS Study Group, Annane D, Vignon P, Renault A et al (2007) Norepinephrine plus dobutamine versus epinephrine alone for manage ment of septic shock: a randomised trial. Lancet 370:676–684
287.
ProCess Investigators, Yealy DM, Kellum JA et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370(18):1683–1693
288.
ARISE Investigators, Anzics Clinical Trials Group, Peake SL, : et al (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371(16):1496–1506
289.
Cohn JN (1967) Blood pressure measurement in shock. Mechanism of inaccuracy in ausculatory and palpatory methods. JAMA 199:118–122PubMed
290.
Hollenberg SM, Parrillo JE (1997) Shock. In: Braunwald E, Isselbacher KJ, Wilson JD et al (Hrsg) Harrison’s principles of internal medicine, 14. Aufl. McGraw-Hill, New York, S 214–222
291.
Scheer B, Perel A, Pfeiffer UJ (2002) Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care 6:199–204PubMedPubMedCentral
292.
Gu WJ, Wu XD, Wang F et al (2016) Ultrasound guidance facilitates radial artery catheterization: a meta-analysis with trial sequential analysis of randomized controlled trials. Chest 149:166–179PubMed
293.
O’Horo JC, Maki DG, Krupp AE et al (2014) Arterial catheters as a source of bloodstream infection: a systematic review and meta-analysis. Crit Care Med 42:1334–1339PubMed
294.
Barton P, Garcia J, Kouatli A et al (1996) Hemodynamic effects of i.v. mil rinone lactate in pediatric patients with septic shock. A prospec tive, double-blinded, randomized, placebo-controlled, interventional study. Chest 109:1302–1312PubMed
295.
Morelli A, Teboul JL, Maggiore SM et al (2006) Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 34:2287–2293PubMed
296.
Morelli A, De Castro S, Teboul JL et al (2005) Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depres sion. Intensive Care Med 31:638–644PubMed
297.
298.
Schmittinger CA, Torgersen C, Luckner G et al (2012) Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 38(6):950–958PubMed
299.
300.
Pemberton P, Veenith T, Snelson C, Whitehouse T (2015) Is it time to beta block the septic patient? Biomed Res Int 2015:424308PubMedPubMedCentral
301.
Lechat P, Packer M, Chalon S et al (1998) Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 98(12):1184–1191PubMed
302.
303.
Garnock-Jones KP (2012) Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension. Drugs 72(1):109–132PubMed
304.
Sanfilippo F, Santonocito C, Morelli A, Foex P (2015) Beta-blocker use in severe sepsis and septic shock: a systematic review. Curr Med Res Opin 31(10):1817–1825PubMed
305.
Morelli A, Ertmer C, Westphal M et al (2013) Effect of heart rate control with esmolol on hemodynamic and clinical Outcomes in patients with septic shock: a randomized clinical trial. JAMA 310(16):1683–1691PubMed
306.
Annane D, Bellissant E, Bollaert PE et al (2009) Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 301:2362–2375PubMed
307.
Bollaert PE, Charpentier C, Levy B et al (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26:645–650PubMed
308.
Briegel J, Forst H, Haller M et al (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723–732PubMed
309.
CORTICUS Study Group, Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124
310.
Sligl WI, Milner DA Jr, Sundar S et al (2009) Safety and efficacy of cortico steroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis 49:93–101PubMed
311.
Volbeda M, Wetterslev J, Gluud C et al (2015) Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 41:1220–1234PubMedPubMedCentral
312.
Annane D, Sébille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMed
313.
CORTICUS Study Group, Briegel J, Sprung CL, Annane D et al (2009) Multicenter comparison of cortisol as measured by different meth ods in samples of patients with septic shock. Intensive Care Med 35:2151–2156
314.
Allolio B, Dörr H, Stuttmann R et al (1985) Effect of a single bolus of etomi date upon eight major corticosteroid hormones and plasma ACTH. Clin Endocrinol 22:281–286
315.
KETASED Collaborative Study Group, Jabre P, Combes X, Lapostolle F et al (2009) Etomidate versus ketamine for rapid sequence intuba tion in acutely ill patients: a multicentre randomised controlled trial. Lancet 374:293–300
316.
Oppert M, Schindler R, Husung C et al (2005) Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyper dynamic septic shock. Crit Care Med 33:2457–2464PubMed
317.
Yildiz O, Doganay M, Aygen B et al (2002) Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care 6:251–259PubMedPubMedCentral
318.
Keh D, Boehnke T, Weber-Cartens S et al (2003) Immunologic and hemo dynamic effects of “low-dose” hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167:512–520PubMed
319.
Huh JW, Choi HS, Lim CM et al (2011) Low-dose hydrocortisone treat ment for patients with septic shock: a pilot study comparing 3days with 7days. Respirology 16:1088–1095PubMed
320.
SepNet–Critical Care Trials Group, Keh D, Trips E, Marx G et al (2016) Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA 316:1775–1785
321.
Weber-Carstens S, Deja M, Bercker S et al (2007) Impact of bolus appli cation of low-dose hydrocortisone on glycemic control in septic shock patients. Intensive Care Med 33:730–733PubMed
322.
Holst LB, Haase N, Wetterslev J et al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371:1381–1391PubMed
323.
Rygard SL, Holst LB, Wetterslev J et al (2016) Long-term Outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial. Intensive Care Med 42:1685–1694PubMed
324.
Dupuis C, Sonneville R, Adrie C et al (2017) Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis. Ann Intensive Care 7:5PubMedPubMedCentral
325.
Dupuis C, Garrouste-Orgeas M, Bailly S et al (2017) Effect of transfusion on mortality and other adverse events among critically ill septic patients: an observational study using a marginal structural cox model. Crit Care Med 45:1972–1980PubMed
326.
Investigators P, Rowan KM, Angus DC et al (2017) Early, goal-directed therapy for septic shock—a patient-level meta-analysis. N Engl J Med 376:2223–2234
327.
Bundesärztekammer (2014) Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten – Herausgegeben von der Bundesärztekammer auf Empfehlung ihres Wissenschaftlichen Beirats, 4. Aufl. Deutscher Ärzte-Verlag, Köln
328.
Corwin HL, Gettinger A, Rodriguez RM et al (1999) Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 27:2346–2350PubMed
329.
Corwin HL, Gettinger A, Pearl RG et al (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288:2827–2835PubMed
330.
Score-Based Immunoglobulin therapy of Sepsis (SBITS) Study Group, Werdan K, Pilz G, Bujdoso O et al (2007) Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 35(200):2693–2701
331.
332.
Laupland KB, Kirkpatrick AW, Delaney A (2007) Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically adults: a systematic review and meta-analysis. Crit Care Med 35:2686–2692PubMed
333.
Pildal J, Gotzsche PC (2004) Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis 39:38PubMed
334.
Kreymann KG, de Heer G, Nierhaus A et al (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 35:2677–2685PubMed
335.
Turgeon AF, Hutton B, Fergusson DA et al (2007) Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 146:193–203PubMed
336.
Shankar-Hari M, Culshaw N, Post B et al (2015) Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis. Intensive Care Med 41:1393–1401PubMed
337.
Welte T, Dellinger RP, Ebelt H et al (2018) Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). Intensive Care Med 44(4):438–448PubMedPubMedCentral
338.
Zhou F, Peng Z, Murugan R et al (2013) Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med 41:2209–2220PubMedPubMedCentral
339.
ABDOMIX Group, Payen DM, Guilhot J, Launey Y et al (2015) Early use of polymyxin B hemoperfusion in patients with septic shock due to peri tonitis: a multicenter randomized control trial. Intensive Care Med 41:975–984
340.
Klein DJ, Foster D, Schorr CA et al (2014) The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial. Trials 15:218PubMedPubMedCentral
341.
EUPHRATES Trial Investigators, Dellinger RP, Bagshaw SM, Antonelli M et al (2018) Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA 320(14):1455–1463
342.
Livigni S, Bertolini G, Rossi C, al GiVi T, GiViTI: Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva (Italian Group for the Evaluation of Interventions in Intensive Care Medicine) is an independent collaboration network of Italian Intensive Care units (2014) Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multi center randomised controlled clinical trial. Bmj Open 4:e3536PubMedPubMedCentral
343.
Schädler D, Pausch C, Heise D et al (2017) The effect of a novel extracorporeal cytokine hemoadsorption Device on IL‑6 elimination in septic patients: A randomized controlled trial. PLoS ONE 12(10):e187015PubMedPubMedCentral
344.
Hawchar F, László I, Öveges N et al (2019) Extracorporeal cytokine adsorption in septic shock: a proof of concept randomized, controlled pilot study. J Crit Care 49:172–178PubMed
345.
346.
Warren BL, Eid A, Singer P et al (2001) Kybersept trial study group: caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286:1869–1878PubMed
347.
Vincent JL, Ramesh MK, Ernest D et al (2013) A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med 41:2069–2079PubMed
348.
Yamakawa K, Ogura H, Fujimi S et al (2013) Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coag ulation: a multicenter propensity score analysis. Intensive Care Med 39:644–652PubMedPubMedCentral
349.
Canadian Critical Care Trials Group, Zarychanski R, Abou-Setta AM, Kanji S et al (2015) The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med 43:511–518
350.
351.
352.
353.
354.
355.
356.
357.
358.
359.
360.
Stewart TE, Meade MO, Cook DJ et al (1998) Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group. N Engl J Med 338(6):355–361PubMed
361.
Brower RG, Shanholtz CB, Fessler HE et al (1999) Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27(8):1492–1498PubMed
362.
Villar J, Kacmarek RM, Perez-Mendez L et al (2006) A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves Outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 34(5):1311–1318PubMed
363.
364.
365.
366.
367.
Serpa Neto A, Schmidt M, Azevedo LCP et al (2016) Associations between ventilator settings during extracorporeal membrane oxygenation for refractory hypoxemia and Outcome in patients with acute respiratory distress syndrome: a pooled individual patient data analysis. Mechanical ventilation during ECMO. Intensive Care Med 42(11):1672–1684. https://​doi.​org/​10.​1007/​s00134-016-4507-0 CrossRefPubMedPubMedCentral
368.
369.
370.
371.
372.
373.
374.
Dasenbrook EC, Needham DM, Brower RG et al (2011) Higher peep in patients with acute lung injury. A systematic review and meta-analysis. Respir Care 56(5):568–575PubMed
375.
376.
377.
378.
Ranieri VM, Suter PM, Tortorella C et al (1999) Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 282(1):54–61PubMed
379.
380.
381.
382.
383.
384.
Lowe GJ, Ferguson ND (2006) Lung-protective ventilation in neurosurgical patients. Curr Opin Crit Care 12(1):3–7PubMed
385.
Suzumura EA, Figueiro M, Normilio-Silva K et al (2014) Effects of alveolar recruitment maneuvers on clinical Outcomes in patients with acute respiratory distress syndrome: a systematic review and meta-analysis. Intensive Care Med 40(9):1227–1240PubMed
386.
Cavalcanti AB et al (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318:1335PubMedPubMedCentral
387.
Maggiore SM, Lellouche F, Pigeot J et al (2003) Prevention of endotracheal suctioning-induced alveolar derecruitment in acute lung injury. Am J Respir Crit Care Med 167(9):1215–1224PubMed
388.
Dyhr T, Bonde J, Larsson A (2003) Lung recruitment manoeuvres are effective in regaining lung volume and oxygenation after open endotracheal suctioning in acute respiratory distress syndrome. Crit Care 7(1):55–62PubMed
389.
390.
Bein T, Bischoff M, Bruckner U et al (2015) Kurzversion S2e-Leitlinie – „Lagerungstherapie und Fruhmobilisation zur Prophylaxe oder Therapie von pulmonalen Funktionsstorungen“ (Short version S2e guidelines: “Positioning therapy and early mobilization for prophylaxis or therapy of pulmonary function disorders”). Anaesthesist 64(8):596–611. https://​doi.​org/​10.​1007/​s00101-015-0060-4 CrossRefPubMed
391.
392.
393.
Davidson JE (2013) Family presence on rounds in neonatal, pediatric, and adult intensive care units. Ann Am Thorac Soc 10:152–156PubMed
394.
Guérin C, Reignier J, Richard JC et al (2013) PROSEVA study group: prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368:2159–2168PubMed
395.
396.
397.
Maitra S, Bhattacharjee S, Khanna P et al (2014) High-frequency ventilation does not provide mortality benefit in comparison with conventional lung-protective ventilation in acute respiratory distress syndrome. A meta-analysis of the randomized controlled trials. Anesthesiology. https://​doi.​org/​10.​1097/​ALN.​0000000000000306​ CrossRef
398.
399.
400.
401.
402.
403.
404.
Putensen C, Zech S, Wrigge H et al (2001) Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 164:43–49PubMed
405.
406.
407.
408.
Zhou Y et al (2017) Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome. Intensive Care Med 43:1648PubMedPubMedCentral
409.
Kiehl M, Schiele C, Stenzinger W et al (1996) Volume-controlled versus biphasic positive airway pressure ventilation in leukopenic patients with severe respiratory failure. Crit Care Med 24:780–784PubMed
410.
Kaplan LJ, Bailey H, Formosa V (2001) Airway pressure release ventilation increases cardiac performance in patients with acute lung injury/adult respiratory distress syndrome. Crit Care 5(4):221–226PubMedPubMedCentral
411.
Gonzalez M, Arroliga AC, Frutos-Vivar F et al (2010) Airway pressure release ventilation versus assist-control ventilation: a comparative propensity score and international cohort study. Intensive Care Med 36:817–827PubMed
412.
413.
Sakr Y, Vincent JL, Reinhart K et al (2005) High tidal volume and positive fluid balance are associated with worse Outcome in acute lung injury. Chest 128(5):3098–3108PubMed
414.
415.
416.
417.
418.
Schönhofer B, Geiseler J, Dellweg D et al (2014) Prolongiertes Weaning. S2k-Leitlinie herausgegeben von der Deutschen Gesellschaftfür Pneumologie und Beatmungsmedizin e.V (Prolonged weaning: S2k-guideline published by the German Respiratory Society). Pneumologie 68(1):19–75. https://​doi.​org/​10.​1055/​s-0033-1359038 CrossRefPubMed
419.
Lung Open Ventilation Study Investigators, Meade MO, Cook DJ, Guyatt GH et al (2008) Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299:637–645
420.
Expiratory Pressure (Express) Study Group, Mercat A, Richard JC, Vielle B et al (2008) Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299:646–655
421.
Ferrer M, Esquinas A, Leon M et al (2003) Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 168:1438–1444PubMed
422.
Antonelli M, Conti G, Rocco M et al (1998) A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 339:429–435PubMed
423.
FLORALI Study Group, REVA Network, Frat JP, Thille AW, Mercat A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372:2185–2196
424.
Ely EW, Baker AM, Dunagan DP et al (1996) Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 335:1864–1869PubMed
425.
Kress JP, Pohlman AS, O’Connor MF et al (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471–1477PubMed
426.
Girard TD, Kress JP, Fuchs BD et al (2008) Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 371:126–134PubMed
427.
Schweickert WD, Pohlman MC, Pohlman AS et al (2009) Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 373:1874–1882PubMed
428.
Sedation Practice in Intensive Care Evaluation (SPICE) Study Investigators, ANZICS Clinical Trials Group, Shehabi Y, Bellomo R, Reade MC et al (2012) Early intensive care sedation predicts long term mortality in ventilated critically ill patients. Am J Respir Crit Care Med 186:724–731
429.
Brook AD, Ahrens TS, Schaiff R et al (1999) Effect of a nursing-imple mented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27:2609–2615PubMed
430.
Bucknall TK, Manias E, Presneill JJ (2008) A randomized trial of protocol directed sedation management for mechanical ventilation in an Australian intensive care unit. Crit Care Med 36:1444–1450PubMed
431.
Kollef MH, Levy NT, Ahrens TS et al (1998) The use of continuous i.v. seda tion is associated with prolongation of mechanical ventilation. Chest 114:541–548PubMed
432.
Carson SS, Kress JP, Rodgers JE et al (2006) A randomized trial of inter mittent lorazepam versus propofol with daily interruption in mechani cally ventilated patients. Crit Care Med 34:1326–1332PubMed
433.
SLEAP Investigators, Canadian Critical Care Trials Group, Mehta S, Burry L, Cook D et al (2012) Daily sedation interruption in mechani cally ventilated critically ill patients cared for with a sedation proto col: a randomized controlled trial. JAMA 308:1985–1992
434.
Jansen JP, Naci H (2013) Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med 11:159PubMedPubMedCentral
435.
Strøm T, Martinussen T, Toft P (2010) A protocol of no sedation for criti cally ill patients receiving mechanical ventilation: a randomised trial. Lancet 375:475–480PubMed
436.
Lonardo NW, Mone MC, Nirula R et al (2014) Propofol is associated with favor-able Outcomes compared with benzodiazepines in ventilated intensive care unit patients. Am J Respir Crit Care Med 189:1383–1394PubMed
437.
Fraser GL, Devlin JW, Worby CP et al (2013) Benzodiazepine versus non-benzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med 41:S30–S38PubMed
438.
DahLIA Investigators; Australian, New Zealand Intensive Care Society Clinical Trials Group, Reade MC, Eastwood GM, Bellomo R et al (2016) Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial. JAMA 315:1460–1468
439.
American College of Critical Care Medicine, Barr J, Fraser GL, Puntillo K et al (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41:263–306
440.
441.
Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367PubMed
442.
Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461PubMed
443.
Arabi YM, Dabbagh OC, Tamim HM et al (2008) Intensive versus conven tional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 36:3190–3197PubMed
444.
Brunkhorst FM, Engel C, Bloos F et al (2008) German Competence Network Sepsis (SepNet): Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139PubMed
445.
De La Gdel RC, Donado JH, Restrepo AH et al (2008) Strict gly caemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 12(5):R120
446.
Finfer S, Blair D, Bellomo R et al (2009) Intensive versus conven tional glucose control in critically ill patients. N Engl J Med 360(13):1283–1297PubMed
447.
Annane D, Cariou A, Maxime V et al (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303(4):341–348PubMed
448.
CGAO-REA Study Group, Kalfon P, Giraudeau B, Ichai C et al (2014) Tight computerized versus conventional glucose control in the ICU: a ran domized controlled trial. Intensive Care Med 40:171–181
449.
Preiser JC, Devos P, Ruiz-Santana S et al (2009) A prospective ran domised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 35:1738–1748PubMed
450.
Zhang RH, Li T et al (2008) Evaluation of optimal goal of glucose con trol in critically ill patients. Chinese J Clin Nutr 16:204–208
451.
Friedrich JO, Chant C, Adhikari NK (2010) Does intensive insulin therapy really reduce mortality in critically ill surgical patients? A reanalysis of meta-analytic data. Crit Care 14:324PubMedPubMedCentral
452.
Griesdale DE, de Souza RJ, van Dam RM et al (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180:821–827PubMed
453.
Kansagara D, Fu R, Freeman M et al (2011) Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 154:268–282PubMed
454.
Marik PE, Preiser JC (2010) Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest 137:544–551PubMed
455.
Wiener RS, Wiener DC, Larson RJ (2008) Benefits and risks of tight glu cose control in critically ill adults: a meta-analysis. JAMA 300:933–944PubMed
456.
Ling Y, Li X, Gao X (2012) Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Intern Med 23:564–574PubMed
457.
Song F, Zhong LJ, Han L et al (2014) Intensive insulin therapy for septic patients: a meta-analysis of randomized controlled trials. Biomed Res Int 2014:698265PubMedPubMedCentral
458.
American Diabetes Association (2014) Standards of medical care in diabe tes—2014. Diabetes Care 37(Suppl 1):S14–S80
459.
Marvin MR, Inzucchi SE, Besterman BJ (2013) Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin. Diabetes Technol Ther 15:246–252PubMedPubMedCentral
460.
Clinical Guidelines Committee of the American College of Physicians, Qaseem A, Chou R, Humphrey LL et al (2014) Inpatient gly cemic control: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Am J Med Qual 29:95–98
461.
Siegelaar SE, Hermanides J, Oudemans-van Straaten HM et al (2010) Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Crit Care 14:R224PubMedPubMedCentral
462.
Badawi O, Waite MD, Fuhrman SA et al (2012) Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med 40:3180–3188PubMed
463.
Finfer S, Liu B, Chittock DR et al (2012) Hypoglycemia and risk of death in critically ill patients. N Engl J Med 367(12):1108–1118PubMed
464.
CGAO-REA Study Group, Kalfon P, Le Manach Y, Ichai C et al (2015) Severe and multiple hypoglycemic episodes are associated with increased risk of death in ICU patients. Crit Care 19:153
465.
Krinsley JS (2008) Glycemic variability: a strong independent predic tor of mortality in critically ill patients. Crit Care Med 36:3008–3013PubMed
466.
Todi S, Bhattacharya M (2014) Glycemic variability and outcome in critically ill. Indian J Crit Care Med 18:285–290PubMedPubMedCentral
467.
Kauffmann RM, Hayes RM, Jenkins JM et al (2011) Provision of balanced nutrition protects against hypoglycemia in the critically ill surgical patient. JPEN J Parenter Enteral Nutr 35:686–694PubMedPubMedCentral
468.
Egi M, Bellomo R, Stachowski E et al (2008) Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 36:2249–2255PubMed
469.
Krinsley JS (2009) Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol 3:1292–1301PubMedPubMedCentral
470.
Krinsley JS, Preiser JC (2015) Time in blood glucose range 70 to 140 mg/dl 〉80 % is strongly associated with increased survival in non-diabetic critically ill adults. Crit Care 19:179PubMedPubMedCentral
471.
Egi M, Bellomo R, Stachowski E et al (2011) The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 39:105–111PubMed
472.
Sandler V, Misiasz MR, Jones J et al (2014) Reducing the risk of hypogly cemia associated with intravenous insulin: experience with a com puterized insulin infusion program in 4 adult intensive care units. J Diabetes Sci Technol 8:923–929PubMedPubMedCentral
473.
Pereira AJ, Corrêa TD, de Almeida FP et al (2015) Inaccuracy of venous point-of-care glucose measurements in critically ill patients: a cross-sectional study. PLoS ONE 10:e129568PubMedPubMedCentral
474.
Hoedemaekers CW, Klein Gunnewiek JM, Prinsen MA et al (2008) Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med 36:3062–3066PubMed
475.
Inoue S, Egi M, Kotani J et al (2013) Accuracy of blood-glucose measure ments using glucose meters and arterial blood gas analyzers in criti cally ill adult patients: systematic review. Crit Care 17:R48PubMedPubMedCentral
476.
Kanji S, Buffie J, Hutton B et al (2005) Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 33:2778–2785PubMed
477.
Khan AI, Vasquez Y, Gray J et al (2006) The variability of results between point-of-care testing glucose meters and the central laboratory ana lyzer. Arch Pathol Lab Med 130:1527–1532PubMed
478.
Rice MJ, Coursin DB (2016) Glucose meters: here today, gone tomorrow? Crit Care Med 44:e97–e100PubMed
479.
Wilson M, Weinreb J, Hoo GW (2007) Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 30:1005–1011PubMed
480.
Dortch MJ, Mowery NT, Ozdas A et al (2008) A computerized insulin infu sion titration protocol improves glucose control with less hypogly cemia compared to a manual titration protocol in a trauma intensive care unit. JPEN J Parenter Enteral Nutr 32:18–27PubMed
481.
Newton CA, Smiley D, Bode BW et al (2010) A comparison study of con tinuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms. J Hosp Med 5:432–437PubMed
482.
Bartlett RH, Mault JR, Dechert RE et al (1986) Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure? Surgery 100:400–408PubMed
483.
Bellomo R, Farmer M, Parkin G et al (1995) Severe acute renal failure: a comparison of acute continuous hemodiafiltration and conventional dialytic therapy. Nephron 71:59–64PubMed
484.
Bellomo R, Mansfield D, Rumble S et al (1992) Acute renal failure in critical illness. Conventional dialysis versus acute continuous hemodiafiltration. ASAIO J 38:M654–M657PubMed
485.
Kierdorf H (1991) Continuous versus intermittent treatment: clinical results in acute renal failure. In: Sieberth HG, Mann H, Stummvoll HK (Hrsg) Continuous Hemofiltration. Karger, Basel, S 1–12
486.
Mauritz W, Sporn P, Schindler I et al (1986) Acute renal failure in abdominal infection. Comparison of hemodialysis and continuous arteriovenous hemofiltration. Anasth Intensivther Notfallmed 21:212–217PubMed
487.
Guérin C, Girard R, Selli JM et al (2002) Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey. Intensive Care Med 28:1411–1418PubMed
488.
van Bommel E, Bouvy ND, So KL et al (1995) Acute dialytic support for the critically ill: intermittent hemodialysis versus continuous arterio venous hemodiafiltration. Am J Nephrol 15:192–200PubMed
489.
Kellum JA, Angus DC, Johnson JP et al (2002) Continuous versus intermit tent renal replacement therapy: a meta-analysis. Intensive Care Med 28:29–37PubMed
490.
Tonelli M, Manns B, Feller-Kopman D (2002) Acute renal failure in the inten sive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40:875–885PubMed
491.
Augustine JJ, Sandy D, Seifert TH et al (2004) A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 44:1000–1007PubMed
492.
Gasparovi V, Filipovi-Grci I, Merkler M, : et al (2003) Continuous renal replacement therapy (CRRT) or intermittent hemodialysis (IHD)—what is the procedure of choice in critically ill patients? Ren Fail 25:855–862
493.
Collaborative Group for Treatment of ARF in the ICU, Mehta RL, McDonald B, Gabbai FB et al (2001) A randomized clinical trial of continu ous versus intermittent dialysis for acute renal failure. Kidney Int 60:1154–1163
494.
Uehlinger DE, Jakob SM, Ferrari P et al (2005) Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 20:1630–1637PubMed
495.
Hemodiafe Study Group, Vinsonneau C, Camus C, Combes A et al (2006) Continuous venovenous haemodiafiltration versus intermittent hae modialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 368:379–385
496.
John S, Griesbach D, Baumgärtel M et al (2001) Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemody namics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant 16:320–327PubMed
497.
Misset B, Timsit JF, Chevret S et al (1996) A randomized cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure. Intensive Care Med 22:742–746PubMed
498.
Bellomo R, Cass A, Cole L et al (2009) Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med 361(17):1627–1638PubMed
499.
Palevsky PM, Zhang JH, O’Connor TZ et al (2008) Intensity of renal sup port in critically ill patients with acute kidney injury. N Engl J Med 359(1):7–20PubMed
500.
Bouman CS, Oudemans-Van Straaten HM, Tijssen JG et al (2002) Effects of early high-volume continuous venovenous hemofiltration on sur¬vival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30:2205–2211PubMed
501.
Zarbock A, Kellum JA, Schmidt C et al (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315:2190–2199PubMed
502.
AKIKI Study Group, Gaudry S, Hajage D, Schortgen F et al (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:122–133
503.
Cooper DJ, Walley KR, Wiggs BR et al (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med 112:492–498PubMed
504.
Mathieu D, Neviere R, Billard V et al (1991) Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic aci dosis: a prospective, controlled clinical study. Crit Care Med 19:1352–1356PubMed
505.
Cook D, Crowther M, Meade M et al (2005) Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33:1565–1571PubMed
506.
Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e195S–e226SPubMedPubMedCentral
507.
Alhazzani W, Lim W, Jaeschke RZ et al (2013) Heparin thromboprophy laxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41:2088–2098PubMed
508.
509.
Xigris and Prophylactic HepaRin Evaluation in Severe Sepsis (XPRESS) Study Group, Levi M, Levy M, Williams MD et al (2007) Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated). Am J Respir Crit Care Med 176:483–490
510.
Beitland S, Sandven I, Kjærvik LK et al (2015) Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 41:1209–1219PubMed
511.
512.
Phung OJ, Kahn SR, Cook DJ et al (2011) Dosing frequency of unfrac tionated heparin thromboprophylaxis: a meta-analysis. Chest 140:374–381PubMed
513.
Mahan CE, Pini M, Spyropoulos AC (2010) Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medi cal patient: the case for thrice daily over twice daily dosing. Intern Emerg Med 5:299–306PubMed
514.
Hull RD et al (1986) Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 315:1109–1114PubMed
515.
Mayr AJ et al (2002) Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin. Thromb Res 105(3):201–204PubMed
516.
517.
518.
519.
Lim W et al (2006) Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 144(9):673–684PubMed
520.
Rabbat CG et al (2005) Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency. J Crit Care 20:357–363PubMed
521.
Canadian Critical Care Trials Group, Douketis J, Cook D, Meade M et al (2008) Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. Arch Intern Med 168:1805–1812
522.
Cook D, Meade M, Guyatt G et al (2011) Dalteparin versus unfrac tionated heparin in critically ill patients. N Engl J Med 364(14):1305–1314PubMed
523.
Canadian Critical Care Trials Group, Australia and New Zealand Intensive Care Society Clinical Trials Group, Fowler RA, Mittmann N, Geerts W et al (2014) Cost-effectiveness of dalteparin vs unfraction ated heparin for the prevention of venous thromboembolism in criti cally ill patients. JAMA 312:2135–2145
524.
Leitlinie „Prophylaxe der venösen Thromboembolie (VTE)“ (AWMF-Leitlinien Register-Nr. 003/001)
525.
526.
527.
Falck-Ytter Y, Francis CW, Johanson NA et al (2012) Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e278S–e325SPubMedPubMedCentral
528.
Gould MK, Garcia DA, Wren SM et al (2012) Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e227S–e277SPubMedPubMedCentral
529.
530.
Arabi YM, Alsolamy S, Al-Dawood A et al (2016) Thromboprophylaxis using combined intermittent pneumatic compression and pharmaco logic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 17:390PubMedPubMedCentral
531.
Pavon JM, Adam SS, Razouki ZA et al (2016) Effectiveness of intermittent pneumatic compression devices for venous thromboembolism prophylaxis in high-risk surgical patients: a systematic review. J Arthroplasty 31:524–532PubMed
532.
533.
Arabi YM, Khedr M, Dara SI et al (2013) Use of intermittent pneumatic compression and not graduated compression stockings is associated with lower incident VTE in critically ill patients: a multiple propensity scores adjusted analysis. Chest 144:152–159PubMed
534.
Canadian Critical Care Trials Group, Cook DJ, Griffith LE, Walter SD et al (2001) The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 5:368–375
535.
Bardou M, Quenot JP, Barkun A (2015) Stress-related mucosal disease in the critically ill patient. Nat Rev Gastroenterol Hepatol 12:98–107PubMed
536.
Cook DJ, Fuller HD, Guyatt GH et al (1994) Risk factors for gastrointes tinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330:377–381PubMed
537.
SUP-ICU co-authors, Krag M, Perner A, Wetterslev J et al (2015) Prevalence and Outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med 41:833–845
538.
Andersson B, Nilsson J, Brandt J et al (2005) Gastrointestinal complica tions after cardiac surgery. Br J Surg 92:326–333PubMed
539.
Bruno JJ, Canada TW, Wakefield CD et al (2009) Stress-related mucosal bleeding in critically ill oncology patients. J Oncol Pharm Pract 15:9–16PubMed
540.
D’Ancona G, Baillot R, Poirier B et al (2003) Determinants of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 30:280–285PubMedPubMedCentral
541.
Faisy C, Guerot E, Diehl JL et al (2003) Clinically significant gastrointes tinal bleeding in critically ill patients with and without stress-ulcer prophylaxis. Intensive Care Med 29:1306–1313PubMed
542.
Krag M, Perner A, Wetterslev J et al (2014) Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med 40:11–22PubMed
543.
Sasabuchi Y, Matsui H, Lefor AK et al (2016) Risks and benefits of stress ulcer prophylaxis for patients with severe sepsis. Crit Care Med 44:e464–e469PubMed
544.
Eastwood GM, Litton E, Bellomo R et al (2014) Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units. Crit Care Resusc 16:170–174PubMed
545.
Preslaski CR, Mueller SW, Kiser TH et al (2014) A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit. J Clin Pharm Ther 39:658–662PubMed
546.
Shears M, Alhazzani W, Marshall JC et al (2016) Stress ulcer prophy laxis in critical illness: a Canadian survey. Can J Anaesth 63:718–724PubMed
547.
Alshamsi F, Belley-Cote E, Cook D et al (2016) Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 20:120PubMedPubMedCentral
548.
Alhazzani W, Alenezi F, Jaeschke RZ et al (2013) Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 41:693–705PubMed
549.
Barkun AN, Bardou M, Pham CQ, Martel M (2012) Proton pump inhibi tors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis. Am J Gastroenterol 107(4):507–520 (quiz 21)PubMed
550.
Alhazzani W et al (2018) Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med 44(1):1–11PubMed
551.
Barkun AN, Adam V, Martel M et al (2013) Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists. Value Health 16:14–22PubMed
552.
MacLaren R, Campbell J (2014) Cost-effectiveness of histamine receptor‑2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients. Crit Care Med 42:809–815PubMed
553.
Alhazzani W et al (2017) Crit Care Med 45(7):1121–1129PubMed
554.
555.
Krag et al (2018) N Eng J Med 379(23):2199–2208
556.
Hartl et al (2013) Aktuel Ernahrmed 38:e90–e100
557.
Elke G, Hartl WH, Kreymann KG, Adolph , Felbinger TW, Graf T, de Heer G, Heller AR, Kampa U, Mayer K, Muhl E, Niemann B, Rümelin A, Steiner S, Stoppe C, Weimann A, Bischoff SC (2018) DGEM Leitlinie Klinische Ernährung in der Intensivmedizin. Aktuel Ernahrungsmed 43:341–408
558.
559.
560.
Weimann A, Felbinger T (2016) Gastrointestinal dysmotility in the critically ill—a role for nutrition. Curr Opin Clin Nutr Metab Care 19:353–359PubMed
561.
Borzotta AP, Pennings J, Papasadero B et al (1994) Enteral versus parenteral nutrition after severe closed head injury. J Trauma 37:459–468PubMed
562.
Adams S, Dellinger EP, Wertz MJ et al (1986) Enteral versus parenteral nutritional support following laparotomy for trauma: a randomized prospective trial. J Trauma 26:882–891PubMed
563.
Dunham CM, Frankenfield D, Belzberg H et al (1994) Gut failure–predictor of or contributor to mortality in mechanically ventilated blunt trauma patients? J Trauma 37:30–34PubMed
564.
CALORIES Trial Investigators, Harvey SE, Parrott F, Harrison DA et al (2014) Trial of the route of early nutritional support in critically ill adults. N Engl J Med 371:1673–1684
565.
Justo Meirelles CM, de Aguilar-Nascimento JE (2011) Enteral or parenteral nutrition in traumatic brain injury: a prospective randomised trial. Nutr Hosp 26:1120–1124PubMed
566.
Kalfarentzos F, Kehagias J, Mead N et al (1997) Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 84:1665–1669PubMed
567.
Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM (1989) TEN versus TPN following major abdominal trauma—reduced septic morbidity. J Trauma 29(7):916–922 (discussion 22–23)PubMed
568.
Peterson VM, Moore EE, Jones TN et al (1988) Total enteral nutrition versus total parenteral nutrition after major torso injury: attenuation of hepatic protein reprioritization. Surgery 104:199–207PubMed
569.
Sun JK, Mu XW, Li WQ et al (2013) Effects of early enteral nutrition on immune function of severe acute pancreatitis patients. World J Gastroenterol 19:917–922PubMedPubMedCentral
570.
Wang G, Wen J, Xu L et al (2013) Effect of enteral nutrition and ecoim-munonutrition on bacterial translocation and cytokine production in patients with severe acute pancreatitis. J Surg Res 183:592–597PubMed
571.
572.
Harvey SE, Parrott F, Harrison DA et al (2016) A multicentre, randomised controlled trial comparing the clinical effectiveness and cost-effectiveness of early nutritional support via the parenteral versus the enteral route in critically ill patients (CALORIES). Health Technol Assess 20:1–144PubMedPubMedCentral
573.
574.
Tian F, Wang X, Gao X, Wan X, Wu C, Zhang L, Li N, Li J (2015) Effect of initial caloric intake via enteral nutrition in critical illness: a meta-analysis of randomised controlled trials. Crit Care 19:180PubMedPubMedCentral
575.
Zhang G, Zhang K, Cui W, Hong Y, Zhang Z (2018) The effect of enteral versus parenteral nutrition for critically ill patients: a systematic review and metaanalysis. J Clin Anesth 51:62–92PubMed
576.
Reignier J, Boisramé-Helms J, Brisard L, Lascarrou JB, Ait Hssain A, Anguel N, Argaud L, Asehnoune K, Asfar P, Bellec F, Botoc V, Bretagnol A, Bui HN, Canet E, Da Silva D, Darmon M, Das V, Devaquet J, Djibre M, Ganster F, Garrouste-Orgeas M, Gaudry S, Gontier O, Guérin C, Guidet B, Guitton C, Herbrecht JE, Lacherade JC, Letocart P, Martino F, Maxime V, Mercier E, Mira JP, Nseir S, Piton G, Quenot JP, Richecoeur J, Rigaud JP, Robert R, Rolin N, Schwebel C, Sirodot M, Tinturier F, Thévenin D, Giraudeau B, Le Gouge A (2018) Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). NUTRIREA‑2 Trial Investigators; Clinical Research in Intensive Care and Sepsis (CRICS) group. Lancet 391(10116):133–143. https://​doi.​org/​10.​1016/​S0140-6736(17)32146-3 CrossRefPubMed
577.
578.
Kudsk KA (2002) Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 183:390–398PubMed
579.
Eyer SD, Micon LT, Konstantinides FN et al (1993) Early enteral feeding does not attenuate metabolic response after blunt trauma. J Trauma 34:639–643 (discussion 643)PubMed
580.
Dvorak MF, Noonan VK, Bölanger L et al (2004) Early versus late enteral feeding in patients with acute cervical spinal cord injury: a pilot study. Spine 29:E175–E180PubMed
581.
Grahm TW, Zadrozny DB, Harrington T (1989) The benefits of early jejunal hyperalimentation in the head-injured patient. Neurosurgery 25:729–735PubMed
582.
Hasse JM, Blue LS, Liepa GU et al (1995) Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr 19:437–443PubMed
583.
Minard G, Kudsk KA, Melton S et al (2000) Early versus delayed feeding with an immune-enhancing diet in patients with severe head injuries. JPEN J Parenter Enteral Nutr 24:145–149PubMed
584.
Moore EE, Jones TN (1986) Benefits of immediate jejunostomy feeding after major abdominal trauma—a prospective, randomized study. J Trauma 26:874–881PubMed
585.
Singh G, Ram RP, Khanna SK (1998) Early postoperative enteral feeding in patients with nontraumatic intestinal perforation and peritonitis. J Am Coll Surg 187:142–146PubMed
586.
Nguyen NQ, Fraser RJ, Bryant LK et al (2008) The impact of delaying enteral feeding on gastric emptying, plasma cholecystokinin, and peptide YY concentrations in critically ill patients. Crit Care Med 36:1469–1474PubMed
587.
Peng YZ, Yuan ZQ, Xiao GX (2001) Effects of early enteral feeding on the prevention of enterogenic infection in severely burned patients. Burns 27:145–149PubMed
588.
Chuntrasakul C, Chinswangwatanakul V, Chockvivatanavanit S, Siltharm S, Pongprasobchai T, Bunnak A (1996) Early nutritional support in severe traumatic patients. J Med Assoc Thai 79(1):21–26PubMed
589.
Chourdakis M, Kraus MM, Tzellos T et al (2012) Effect of early compared with delayed enteral nutrition on endocrine function in patients with traumatic brain injury: an open-labeled randomized trial. JPEN J Parenter Enteral Nutr 36:108–116PubMed
590.
Doig GS, Heighes PT, Simpson F et al (2011) Early enteral nutrition reduces mortality in trauma patients requiring intensive care: a metaanalysis of randomised controlled trials. Injury 42:50–56PubMed
591.
Doig GS, Heighes PT, Simpson F et al (2009) Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med 35:2018–2027PubMed
592.
Malhotra A, Mathur AK, Gupta S (2004) Early enteral nutrition after surgical treatment of gut perforations: a prospective randomised study. J Postgrad Med 50:102–106PubMed
593.
Pupelis G, Austrums E, Jansone A et al (2000) Randomised trial of safety and efficacy of postoperative enteral feeding in patients with severe pancreatitis: preliminary report. Eur J Surg 166:383–387PubMed
594.
Arabi YM, Aldawood AS, Haddad SH et al (2015) PermiT trial group: permissive underfeeding or standard enteral feeding in critically ill adults. N Engl J Med 372:2398–2408PubMed
595.
Marik PE, Hooper MH (2016) Normocaloric versus hypocaloric feeding on the Outcomes of ICU patients: a systematic review and meta-analysis. Intensive Care Med 42:316–323PubMed
596.
Arabi YM, Tamim HM, Dhar GS et al (2011) Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial. Am J Clin Nutr 93:569–577PubMed
597.
Charles EJ, Petroze RT, Metzger R et al (2014) Hypocaloric compared with eucaloric nutritional support and its effect on infection rates in a surgical intensive care unit: a randomized controlled trial. Am J Clin Nutr 100:1337–1343PubMedPubMedCentral
598.
Ibrahim EH, Mehringer L, Prentice D et al (2002) Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 26:174–181PubMed
599.
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Rice TW, Wheeler AP et al (2012) Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA 307(8):795–803
600.
Petros S, Horbach M, Seidel F et al (2016) Hypocaloric vs normocaloric nutrition in critically ill patients: a prospective randomized pilot trial. JPEN J Parenter Enteral Nutr 40:242–249PubMed
601.
Rice TW, Mogan S, Hays MA et al (2011) Randomized trial of initial trophic versus full-energy enteral nutrition in mechanically ventilated patients with acute respiratory failure. Crit Care Med 39:967–974PubMedPubMedCentral
602.
Needham DM, Dinglas VD, Bienvenu OJ et al (2013) One year Outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective followup of EDEN randomised trial. BMJ 346:f1532PubMedPubMedCentral
603.
604.
Choi EY, Park DA, Park J (2015) Calorie intake of enteral nutrition and clinical Outcomes in acutely critically ill patients: a meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 39:291–300PubMed
605.
Casaer MP, Mesotten D, Hermans G et al (2011) Early versus late parenteral nutrition in critically ill adults. N Engl J Med 365:506–517PubMed
606.
Early PN Investigators of the ANZICS Clinical Trials Group, Doig GS, Simpson F, Sweetman EA et al (2013) Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial. JAMA 309:2130–2138
607.
Young B, Ott L, Haack D et al (1987) Effect of total parenteral nutrition upon intracranial pressure in severe head injury. J Neurosurg 67:76–80PubMed
608.
Rapp RP, Donaldson ES, Bivins BA (1983) Parenteral nutrition in a patient with familial Type IV hypertriglyceridemia: a dilemma. Drug Intell Clin Pharm 17(6):458–460PubMed
609.
Sadique Z, Grieve R, Harrison D et al (2015) Cost-effectiveness of early parenteral versus enteral nutrition in critically ill patients. Value Health 18:A532
610.
The TARGET Investigators for the ANZICS Clinical Trials Group. (2018) Energy-dense versus routine enteral nutrition in the critically ill. N Engl J Med 379:823–834
611.
Allingstrup MJ, Kondrup J, Wiis J, Claudius C, Pedersen UG, Hein-Rasmussen R, Bjerregaard MR, Steensen M, Jensen TH, Lange T, Madsen MB, Møller MH, Perner A (2017) Early goal-directed nutrition versus standard of care in adult intensive care patients: the single-centre, randomised, Outcome assessor-blinded EAT-ICU trial. Intensive Care Med 43(11):1637–1647. https://​doi.​org/​10.​1007/​s00134-017-4880-3 CrossRefPubMed
612.
Stuani Franzosi O, Delfino von Frankenberg A, Loss SH, Solva Leite Nunes D, Rios Vieiira SR (2017) Underfeeding versus full enteral feeding in critically ill patients witrh acute respirartoryx failure: a systematic review with meta-analyis of randomized controlled trials. Nutr Hosp 34:19–29PubMed
613.
Yeh DD, Fuentes E, Quraishi SA, Cropano C, Kaafarani H, Lee J, King DR, DeMoya M, Fagenholz P, Butler K, Chang Y, Velmahos G (2016) Adequate nutrition may get you home: effect of caloric/protein deficits on the discharge destination of critically ill surgical patients. JPEN J Parenter Enteral Nutr 40:37–44PubMed
614.
Nicolo M, Heyland DK, Crittiams J, Sammarco T, Compher C (2016) Clinical Outcomes related toprotein delivery in a critically ill population: a multicenter,multinational observational study. JPEN J Parenter Enteral Nutr 40(1):45–51PubMed
615.
Zusman O, Theilla M, Cohen J, Kagan I, Bendavid I, Singer P (2016) Resting energy expenditure, calorie and protein consumption in critically ill patients: a retrospective cohort study. Crit Care 20(1):367PubMedPubMedCentral
616.
Compher C, Chittams J, Sammero T, Nicolo M, Heyland DK (2017) Greater protein and energy intake may be associated with improved mortality in higher risk critically ill patients: a multicenter multinational observational study. Crit Care Med 41:104–112
617.
618.
A.S.P.E.N. Board of Directors, American College of Critical Care Medicine, Society of Critical Care Medicine Guidelines for the Provision, Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient, Society of Critical Care Medicine (SCCM), American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.), McClave SA, McClave SA, Taylor BE, Martindale RG, Warren MM et al (2016) Important and most recent guideline regarding clinical nutrition in the ICU. JPEN J Parenter Enteral Nutr 40:159–211
619.
McClave SA, DeMeo MT, DeLegge MH et al (2002) North American Summit on Aspiration in the Critically Ill Patient: consensus statement. JPEN J Parenter Enteral Nutr 26:S80–S85PubMed
620.
McClave SA, Lukan JK, Stefater JA et al (2005) Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients. Crit Care Med 33:324–330PubMed
621.
Metheny NA, Schallom L, Oliver DA, Clouse RE (2008) Gastric residual volume and aspiration in critically ill patients receiving gastric feedings. Am J Crit Care 17(6):512–519 (quiz 20)PubMedPubMedCentral
622.
Montejo JC, Miñambres E, Bordejö L et al (2010) Gastric residual volume during enteral nutrition in ICU patients: the REGANE study. Intensive Care Med 36:1386–1393PubMed
623.
Poulard F, Dimet J, Martin-Lefevre L et al (2010) Impact of not measuring residual gastric volume in mechanically ventilated patients receiving early enteral feeding: a prospective before-after study. JPEN J Parenter Enteral Nutr 34:125–130PubMed
624.
Clinical Research in Intensive Care and Sepsis (CRICS) Group, Reignier J, Mercier E, Le Gouge A et al (2013) Effect of not monitoring residual gastric volume on risk of ventilator-associated pneumonia in adults receiving mechanical ventilation and early enteral feeding: a randomized controlled trial. JAMA 309:249–256
625.
626.
van Noord C, Dieleman JP, van Herpen G et al (2010) Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based casecontrol study in the Netherlands. Drug Saf 33:1003–1014PubMed
627.
Ray WA, Murray KT, Meredith S et al (2004) Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 351:1089–1096PubMed
628.
Lewis K, Alqahtani Z, Mcintyre L et al (2016) The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials. Crit Care 20:259PubMedPubMedCentral
629.
BDDixon DJCoopersmith FCM et al (2008) Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients. Pharmacoepidemiol Drug Saf 17:971–981
630.
631.
Mentec H, Dupont H, Bocchetti M et al (2001) Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med 29:1955–1961PubMed
632.
Zaloga GP, Marik P (2000) Promotility agents in the intensive care unit. Crit Care Med 28:2657–2659PubMed
633.
Tiancha H, Jiyong J, Min Y (2015) How to promote bedside placement of the postpyloric feeding tube: a network meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 39:521–530PubMed
634.
Alhazzani W, Almasoud A, Jaeschke R et al (2013) Small bowel feeding and risk of pneumonia in adult critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 17:R127PubMedPubMedCentral
635.
Valenta J, Brodska H, Drabek T et al (2011) High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med 37:808–815PubMed
636.
Bloos F, Trips E, Nierhaus A, Briegel J, Heyland DK, Jaschinski U, Moerer O, Weyland A, Marx G, Gründling M, Kluge S, Kaufmann I, Ott K, Quintel M, Jelschen F, Meybohm P, Rademacher S, Meier-Hellmann A, Utzolino S, Kaisers UX, Putensen C, Elke G, Ragaller M, Gerlach H, Ludewig K, Kiehntopf M, Bogatsch H, Engel C, Brunkhorst FM, Loeffler M, Reinhart K, SepNet Critical Care Trials Group Effect of Sodium Selenite Administration, Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock (2016) A randomized clinical trial. JAMA Intern Med 176(9):1266–1276. https://​doi.​org/​10.​1001/​jamainternmed.​2016.​2514 CrossRefPubMed
637.
SepNet Critical Care Trials Group, Bloos F, Trips E, Nierhaus A et al (2016) Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA Intern Med 176:1266–1276
638.
Marik PE, Zaloga GP (2001) Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med 29:2264–2270PubMed
639.
Avenell A (2006) Glutamine in critical care: current evidence from systematic reviews. Proc Nutr Soc 65:236–241PubMed
640.
Avenell A (2009) Hot topics in parenteral nutrition. Current evidence and ongoing trials on the use of glutamine in critically-ill patients and patients undergoing surgery. Proc Nutr Soc 68:261–268PubMed
641.
Jiang H, Chen W, Hu W et al (2009) The impact of glutamine-enhanced enteral nutrition on clinical Outcome of patients with critical illness: a systematic review of randomized controlled trials. Zhonghua Shao Shang Za Zhi 25:325–330PubMed
642.
Novak F, Heyland DK, Avenell A et al (2002) Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 30:2022–2029PubMed
643.
Metabolism, Nutrition Working Group, SEMICYUC, Spain, Grau T, Bonet A, Miñambres E et al (2011) The effect of L‑alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med 39:1263–1268
644.
Wang Z, Forceville X, Van Antwerpen P et al (2009) A large-bolus injection, but not continuous infusion of sodium selenite improves Outcome in peritonitis. Shock 32:140–146PubMed
645.
Scandinavian Critical Care Trials Group, Wernerman J, Kirketeig T, Andersson B et al (2011) Scandinavian glutamine trial: a pragmatic multicentre randomised clinical trial of intensive care unit patients. Acta Anaesthesiol Scand 55:812–818
646.
Canadian Critical Care Trials Group, Heyland D, Muscedere J, Wischmeyer PE et al (2013) A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368:1489–1497
647.
Beale RJ, Sherry T, Lei K et al (2008) Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: Outcome of a randomized, controlled, double-blind trial. Crit Care Med 36:131–144PubMed
648.
Fuentes-Orozco C, Anaya-Prado R, González-Ojeda A et al (2004) L‑alanylL-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr 23:13–21PubMed
649.
McRae MP (2017) Therapeutic benefits of glutamine: an umbrella review of meta-analyses. Biomed Rep 6:576–584PubMedPubMedCentral
650.
Stehle P, Ellger B, Kojic D, Feuersenger A, Schneid C, Stover J, Scheiner D, Westphal M (2017) Glutamine dipeptide—supplemented parenteral nutrition improves the clinical ouitcomes of critically ill patients: a systematic evaluation of randomized controlled trials. Clin Nutr ESPEN 17:75–85PubMed
651.
Garcia de Acilu M, Leal S, Caralt B, Roca O, Sabater J, Masclans JR (2015) The role of omega‑3 polyunsaturated fatty acids in the treatment of patients with acute respiratory distress syndrome: a clinical review. Biomed Res Int 2015:653750PubMedPubMedCentral
652.
NIH NHLBI Acute Respiratory Distress Syndrome Network of Investigators, NHLBI ARDS Clinical Trials Network, Rice TW, Wheeler AP, Thompson BT et al (2011) Enteral omega‑3 fatty acid, gammalinolenic acid, and antioxidant supplementation in acute lung injury. JAMA 306:1574–1581PubMedCentral
653.
654.
Chen H, Wang S, Zhao Y et al (2018) Correlation analysis of omega‑3 fatty acids and mortality of sepsis and sepsis-induced ARDS in adults: data from previous randomized controlled trials. Nutr J 17(1):57PubMedPubMedCentral
655.
656.
657.
White DB, Engelberg RA, Wenrich MD et al (2010) The language of prognostication in intensive care units. Med Decis Making 30:76–83PubMed
658.
Chiarchiaro J, Buddadhumaruk P, Arnold RM et al (2015) Quality of communication in the ICU and surrogate’s understanding of prognosis. Crit Care Med 43:542–548PubMedPubMedCentral
659.
Canadian Critical Care Trials Group, Downar J, You JJ, Bagshaw SM et al (2015) Nonbeneficial treatment Canada: definitions, causes, and potential solutions from the perspective of healthcare practitioners. Crit Care Med 43:270–281
660.
Improving Palliative Care in the ICU (IPAL-ICU) Project Advisory Board, Nelson JE, Curtis JR, Mulkerin C et al (2013) Choosing and using screening criteria for palliative care consultation in the ICU: a report from the Improving Palliative Care in the ICU (IPAL-ICU) Advisory Board. Crit Care Med 41:2318–2327
661.
Detering KM, Hancock AD, Reade MC et al (2010) The impact of advance care planning on end of life care in elderly patients: randomised con trolled trial. BMJ 340:c1345PubMedPubMedCentral
662.
Scheunemann LP, McDevitt M, Carson SS et al (2011) Randomized, con trolled trials of interventions to improve communication in intensive care: a systematic review. Chest 139:543–554PubMed
663.
American Thoracic Society ad hoc Committee on Futile and Potentially Inappropriate Treatment, American Thoracic Society, American Association for Critical Care Nurses, American College of Chest Physicians, European Society for Intensive Care Medicine; Society of Critical Care, Bosslet GT, Bosslet GT, Pope TM, Rubenfeld GD et al (2015) An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units. Am J Respir Crit Care Med 191:1318–1330
664.
American College of Critical Care Medicine, American Thoracic Society: Shared Decision Making in ICUs, Kon AA, Davidson JE, Morrison W et al (2016) An American college of critical care medicine and American thoracic society policy statement. Crit Care Med 44:188–201
665.
Aslakson R, Cheng J, Vollenweider D et al (2014) Evidence-based pallia tive care in the intensive care unit: a systematic review of interven tions. J Palliat Med 17:219–235PubMedPubMedCentral
666.
Schulz V, Novick RJ (2013) The distinct role of palliative care in the sur gical intensive care unit. Semin Cardiothorac Vasc Anesth 17:240–248PubMed
667.
Khandelwal N, Kross EK, Engelberg RA et al (2015) Estimating the effect of palliative care interventions and advance care planning on ICU utilization: a systematic review. Crit Care Med 43:1102–1111PubMedPubMedCentral
668.
DeCato TW, Engelberg RA, Downey L et al (2013) Hospital variation and temporal trends in palliative and end-of-life care in the ICU. Crit Care Med 41:1405–1411PubMedPubMedCentral
669.
Sprung CL, Truog RD, Curtis JR et al (2014) Seeking worldwide profes sional consensus on the principles of end-of-life care for the critically ill. The Consensus for Worldwide End-of-Life Practice for Patients in Intensive Care Units (WELPICUS) study. Am J Respir Crit Care Med 190:855–866PubMed
670.
Flanders SA, Strasen JH (2014) Review of evidence about family pres ence during resuscitation. Crit Care Nurs Clin North Am 26:533–550PubMed
671.
Oczkowski SJ, Mazzetti I, Cupido C et al (2015) The offering of family presence during resuscitation: a systematic review and meta-analysis. J Intensive Care 3:41PubMedPubMedCentral
672.
Oczkowski SJ, Mazzetti I, Cupido C et al (2015) Canadian critical care society: family presence during resuscitation: a Canadian critical care society position paper. Can Respir J 22:201:205vv
673.
Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA (2000) Long-term health-related quality of life in survivors of sepsis. Short Form 36: a valid and reliable measure of health-related quality of life. Crit Care Med 28(11):3599–3605PubMed
674.
Korosec Jagodic H, Jagodic K, Podbregar M (2006) Long-term outcome and quality of life of patients treated in surgical intensive care: a comparison between sepsis and trauma. Crit Care 10(5):R134PubMedPubMedCentral
675.
Granja C, Dias C, Costa-Pereira A, Sarmento A (2004) Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness. Crit Care 8(2):R91–R98PubMedPubMedCentral
676.
Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ (1984) Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 47(11):1223–1231PubMedPubMedCentral
677.
Tepper M, Rakic S, Haas JA, Woittiez AJ (2000) Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med 56(6):211–214PubMed
678.
Davydow DS, Gifford JM, Desai SV, Bienvenu OJ, Needham DM (2009) Depression in general intensive care unit survivors: a systematic review. Intensive Care Med 35(5):796–809PubMed
679.
Schelling G (2008) Post-traumatic stress disorder in somatic disease: lessons from critically ill patients. Prog Brain Res 167:229–237PubMed
680.
Mehlhorn J, Freytag A, Schmidt K et al (2014) Crit Care Med 42(5):1263–1271PubMed
681.
Graf J, Doig GS, Cook DJ, Vincent JL, Sibbald WJ (2002) Randomized, controlled clinical trials in sepsis: has methodologicalquality improved over time? Crit Care Med 30(2):461–472PubMed
682.
683.
S3-Leitlinie der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin e. V., der Deutschen Gesellschaft für Infektiologie e. V., der Deutschen Gesellschaft für Hygiene und Mikrobiologie e. V., der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., der Paul-Ehrlich Gesellschaft für Chemotherapie e.V, der Deutschen Röntgengesellschaft und der Gesellschaft für Virologie. Pneumologie 2018; 72(01): 15–63
684.
685.
686.
Zhoe SX (2002) Acta Pharmacol Sin 23(7):654–658
687.
688.
689.
690.
691.
Luiking YC, Poeze M, Deutz NE (2015) Arginine infusion in patients with septic shock increases nitric oxide production without hemodynamic instability. Clin Sci 128:57–67
692.
Metadaten
Titel
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Langfassung
verfasst von
Prof. Dr. med. F. M. Brunkhorst
M. A. Weigand
M. Pletz
P. Gastmeier
S. W. Lemmen
A. Meier-Hellmann
M. Ragaller
A. Weyland
G. Marx
M. Bucher
H. Gerlach
B. Salzberger
B. Grabein
T. Welte
K. Werdan
S. Kluge
H. G. Bone
C. Putensen
R. Rossaint
M. Quintel
C. Spies
B. Weiß
S. John
M. Oppert
A. Jörres
T. Brenner
G. Elke
M. Gründling
K. Mayer
A. Weimann
T. W. Felbinger
H. Axer
Deutsche Sepsis Gesellschaft e. V.
Publikationsdatum
30.04.2020
Verlag
Springer Medizin
Erschienen in
Medizinische Klinik - Intensivmedizin und Notfallmedizin / Ausgabe Sonderheft 2/2020
Print ISSN: 2193-6218
Elektronische ISSN: 2193-6226
DOI
https://doi.org/10.1007/s00063-020-00685-0

Neu im Fachgebiet AINS

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

11.04.2024 | Rückenschmerzen | Nachrichten

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren